SAR 10-Q Quarterly Report Nov. 30, 2014 | Alphaminr
SARATOGA INVESTMENT CORP.

SAR 10-Q Quarter ended Nov. 30, 2014

SARATOGA INVESTMENT CORP.
10-Ks and 10-Qs
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
10-Q 1 d847228d10q.htm FORM 10-Q Form 10-Q
Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended November 30, 2014

¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 1-33376

SARATOGA INVESTMENT CORP.

(Exact name of registrant as specified in its charter)

Maryland 20-8700615

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

535 Madison Avenue

New York, New York

10022
(Address of principal executive office) (Zip Code)

(212) 906-7800

(Registrant’s telephone number, including area code)

Not applicable

(Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.     Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     Yes ¨ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (check one):

Large Accelerated Filer ¨ Accelerated Filer ¨
Non-Accelerated Filer x Smaller Reporting Company ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ¨ No x

The number of shares of the registrant’s common stock, $0.001 par value, outstanding as of January 14, 2015 was 5,401,899.


Table of Contents

TABLE OF CONTENTS

Page

PART I

FINANCIAL INFORMATION

Item 1.

Financial Statements 3
Consolidated Statements of Assets and Liabilities as of November 30, 2014 (unaudited) and February 28, 2014 3
Consolidated Statements of Operations for the three and nine months ended November 30, 2014 and November 30, 2013 (unaudited) 4
Consolidated Schedules of Investments as of November 30, 2014 (unaudited) and February 28, 2014 5
Consolidated Statements of Changes in Net Assets for the nine months ended November 30, 2014 and November 30, 2013 (unaudited) 11
Consolidated Statements of Cash Flows for the nine months ended November 30, 2014 and November 30, 2013 (unaudited) 12
Notes to Consolidated Financial Statements as of November 30, 2014 (unaudited) 13

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations 33

Item 3.

Quantitative and Qualitative Disclosures About Market Risk 52

Item 4.

Controls and Procedures 52

PART II

OTHER INFORMATION 52

Item 1.

Legal Proceedings 52

Item 1A.

Risk Factors 53

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds 53

Item 3.

Defaults upon Senior Securities 53

Item 4.

Mine Safety Disclosures 53

Item 5.

Other Information 53

Item 6.

Exhibits 53

Signatures

54


Table of Contents

PART I FINANCIAL INFORMATION

Item 1. Financial Statements

Saratoga Investment Corp.

Consolidated Statements of Assets and Liabilities

As of
November 30, 2014 February 28, 2014
(unaudited)

ASSETS

Investments at fair value

Non-control/non-affiliate investments (amortized cost of $222,452,952 and $185,266,607, respectively)

$ 221,740,190 $ 186,275,106

Control investments (cost of $16,384,467 and $16,555,808, respectively)

19,433,253 19,569,596

Total investments at fair value (amortized cost of $238,837,419 and $201,822,415, respectively)

241,173,443 205,844,702

Cash and cash equivalents

809,245 3,293,898

Cash and cash equivalents, reserve accounts

10,738,075 3,293,113

Interest receivable, (net of reserve of $411,334 and $150,058, respectively)

3,170,976 2,571,853

Deferred debt financing costs, net

4,921,925 4,008,704

Management fee receivable

178,234 150,106

Other assets

8,583 14,461

Total assets

$ 261,000,481 $ 219,176,837

LIABILITIES

Revolving credit facility

$ 4,900,000 $

SBA debentures payable

79,000,000 50,000,000

Notes payable

48,300,000 48,300,000

Dividend payable

320,189

Management and incentive fees payable

4,551,236 3,856,962

Accounts payable and accrued expenses

550,565 824,568

Interest and debt fees payable

725,301 873,135

Due to manager

337,433 398,154

Total liabilities

$ 138,684,724 $ 104,252,819

Commitments and contingencies (See Note 7)

NET ASSETS

Common stock, par value $.001, 100,000,000 common shares authorized, 5,379,616 and 5,379,616 common shares issued and outstanding, respectively

$ 5,380 $ 5,380

Capital in excess of par value

184,851,154 184,851,154

Distribution in excess of net investment income

(23,752,974 ) (29,627,578 )

Accumulated net realized loss from investments and derivatives

(41,123,827 ) (44,327,225 )

Net unrealized appreciation on investments and derivatives

2,336,024 4,022,287

Total net assets

122,315,757 114,924,018

Total liabilities and net assets

$ 261,000,481 $ 219,176,837

NET ASSET VALUE PER SHARE

$ 22.74 $ 21.36

See accompanying notes to consolidated financial statements.

3


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Operations

(unaudited)

For the three months ended
November 30
For the nine months ended
November 30
2014 2013 2014 2013

INVESTMENT INCOME

Interest from investments

Non-control/Non-affiliate investments

$ 5,038,877 $ 4,279,445 $ 14,794,342 $ 11,534,271

Payment-in-kind interest income from Non-control/Non-affiliate investments

319,994 161,485 902,536 634,408

Control investments

694,641 556,291 1,996,010 2,791,830

Total interest income

6,053,512 4,997,221 17,692,888 14,960,509

Interest from cash and cash equivalents

1,024 1,316 2,738 7,181

Management fee income

383,012 421,198 1,150,505 1,400,039

Other income

867,409 381,480 1,078,239 838,956

Total investment income

7,304,957 5,801,215 19,924,370 17,206,685

EXPENSES

Interest and debt financing expenses

1,869,176 1,611,221 5,466,279 4,342,657

Base management fees

1,087,734 876,345 3,093,399 2,424,167

Professional fees

225,776 312,992 937,083 879,247

Administrator expenses

250,000 250,000 750,000 750,000

Incentive management fees

851,806 (561,539 ) 2,022,423 219,813

Insurance

83,388 117,955 252,002 357,184

Directors fees and expenses

51,000 35,978 159,761 131,978

General & administrative

176,293 251,058 400,487 440,844

Other expense

9,172 21,207

Total expenses

4,595,173 2,903,182 13,081,434 9,567,097

NET INVESTMENT INCOME

2,709,784 2,898,033 6,842,936 7,639,588

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

Net realized gain from investments

2,761,558 82,882 3,203,399 1,157,824

Net unrealized depreciation on investments

(2,005,072 ) (1,713,025 ) (1,686,263 ) (3,770,968 )

Net gain/(loss) on investments

756,486 (1,630,143 ) 1,517,136 (2,613,144 )

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

$ 3,466,270 $ 1,267,890 $ 8,360,072 $ 5,026,444

WEIGHTED AVERAGE—BASIC AND DILUTED EARNINGS PER COMMON SHARE

$ 0.64 $ 0.26 $ 1.55 $ 1.05

WEIGHTED AVERAGE COMMON STOCK OUTSTANDING—BASIC AND DILUTED

5,379,616 4,851,451 5,379,616 4,770,267

See accompanying notes to consolidated financial statements.

4


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

November 30, 2014

(unaudited)

Company

Industry

Investment Interest Rate /
Maturity

Principal/
Number
of Shares
Cost Fair Value (c) % of
Net Assets

Non-control/Non-affiliated investments—181.3% (b)

National Truck Protection Co.,
Inc. (d), (g)

Automotive Aftermarket Common Stock 1,116 $ 1,000,000 $ 1,631,710 1.3 %

National Truck Protection Co., Inc. (d)

Automotive Aftermarket First Lien Term Loan 15.50% Cash, 9/13/2018 $ 7,737,848 7,737,848 7,737,848 6.3 %

Take 5 Oil Change, L.L.C. (d), (g)

Automotive Aftermarket Common Stock 7,128 480,536 1,347,406 1.2 %

Total Automotive Aftermarket 9,218,384 10,716,964 8.8 %

Legacy Cabinets Holdings (d), (g)

Building Products Common Stock Voting A-1 2,535 220,900 1,468,475 1.2 %

Legacy Cabinets Holdings (d), (g)

Building Products Common Stock Voting B-1 1,600 139,425 926,848 0.8 %

Total Building Products 360,325 2,395,323 2.0 %

BMC Software, Inc. (d)

Business Services First Lien Term Loan 5.00% Cash, 9/10/2020 $ 5,746,667 5,699,544 5,650,123 4.6 %

Dispensing Dynamics International (d)

Business Services Senior Secured Note 12.50% Cash, 1/1/2018 $ 7,000,000 6,903,658 7,490,000 6.1 %

Easy Ice, LLC (d)

Business Services First Lien Term Loan 14.00% (11.00% Cash/3.00% PIK), 3/29/2018 $ 7,661,668 7,588,434 7,661,669 6.3 %

Emily Street Enterprises, L.L.C.

Business Services Senior Secured Note 12.00% (11.00% Cash/1.00% PIK), 12/28/2017 $ 5,807,354 5,711,778 5,807,354 4.7 %

Emily Street Enterprises, L.L.C. (g)

Business Services Warrant Membership Interests 49,318 400,000 375,310 0.3 %

Help/Systems Holdings, Inc. (Help/Systems, LLC) (d)

Business Services First Lien Term Loan 5.50% Cash, 6/28/2019 $ 1,960,000 1,945,399 1,940,400 1.6 %

Help/Systems Holdings, Inc. (Help/Systems, LLC) (d)

Business Services Second Lien Term Loan 9.50% Cash, 6/28/2020 $ 2,000,000 1,974,499 1,990,000 1.6 %

Knowland Technology Holdings, L.L.C.

Business Services First Lien Term Loan 11.00% Cash, 11/29/2017 $ 5,259,171 5,212,134 5,259,171 4.3 %

Vector Controls Holding Co., LLC (d)

Business Services First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018 $ 9,387,880 9,255,555 9,387,880 7.7 %

Vector Controls Holding Co., LLC (d), (g)

Business Services Warrants to Purchase Limited Liability Company Interests 100 34,373 0.0 %

Total Business Services 44,691,001 45,596,280 37.2 %

Targus Group International, Inc. (d)

Consumer Products First Lien Term Loan 11.00% Cash, 5/24/2016 $ 3,622,544 3,581,235 3,443,590 2.8 %

Targus Holdings, Inc. (d), (g)

Consumer Products Common Stock 62,413 566,765 0.0 %

Targus Holdings, Inc. (d)

Consumer Products Unsecured Note 10.00% PIK, 6/14/2019 $ 2,054,158 2,054,158 1,473,654 1.2 %

Targus Holdings, Inc. (d)

Consumer Products Unsecured Note 16.00% Cash, 10/26/2018 $ 437,547 425,624 394,352 0.3 %

Total Consumer Products 6,627,782 5,311,596 4.3 %

Avionte Holdings, LLC (g)

Consumer Services Common Stock 100,000 100,000 142,000 0.1 %

Avionte Holdings, LLC

Consumer Services First Lien Term Loan 8.25% Cash, 1/8/2019 $ 3,000,000 2,948,818 3,000,000 2.5 %

CFF Acquisition L.L.C. (d)

Consumer Services First Lien Term Loan 7.50% Cash, 7/31/2015 $ 824,554 821,089 824,554 0.7 %

Expedited Travel L.L.C. (g)

Consumer Services Common Stock 1,000,000 1,000,000 1,000,000 0.8 %

Expedited Travel L.L.C.

Consumer Services First Lien Term Loan 10.00% Cash, 10/10/2019 $ 14,000,000 13,845,224 14,000,000 11.4 %

PrePaid Legal Services, Inc. (d)

Consumer Services First Lien Term Loan 6.25% Cash, 7/1/2019 $ 3,870,968 3,839,277 3,870,968 3.2 %

PrePaid Legal Services, Inc. (d)

Consumer Services Second Lien Term Loan 9.75% Cash, 7/1/2020 $ 5,000,000 4,934,739 5,025,000 4.1 %

Total Consumer Services 27,489,147 27,862,522 22.8 %

M/C Acquisition Corp., L.L.C. (d), (g)

Education Class A Common Stock 544,761 30,241 0.0 %

M/C Acquisition Corp., L.L.C. (d)

Education First Lien Term Loan 1.00% Cash, 3/31/2015 $ 2,362,978 1,235,695 100,951 0.1 %

Total Education 1,265,936 100,951 0.1 %

Group Dekko, Inc. (d)

Electronics Second Lien Term Loan 11.00% (10.00% Cash/1.00% PIK), 5/1/2016 $ 6,954,060 6,954,060 6,470,753 5.3 %

Total Electronics 6,954,060 6,470,753 5.3 %

5


Table of Contents

TB Corp. (d)

Food and Beverage

First Lien Term Loan

5.75% Cash, 6/19/2018

$ 5,063,319 5,052,788 5,027,876 4.1 %

TB Corp. (d)

Food and Beverage

Unsecured Note

13.50% (12.00% Cash/1.50% PIK), 12/20/2018

$ 2,546,121 2,517,643 2,546,121 2.1 %

TM Restaurant Group L.L.C.

Food and Beverage First Lien Term Loan 7.75% Cash, 7/16/2017 $ 2,799,893 2,799,893 2,794,573 2.3 %

Total Food and Beverage 10,370,324 10,368,570 8.5 %

Bristol Hospice, LLC

Healthcare Services

Senior Secured Note

11.00%(10.00% Cash/1.00% PIK),

11/29/2018

$ 5,472,816 5,384,210 5,472,816 4.4 %

IDOC, LLC

Healthcare Services

First Lien Term Loan

9.75% Cash, 8/2/2017

$ 13,644,083 13,659,669 13,644,083 11.1 %

Roscoe Medical, Inc. (d), (g)

Healthcare Services Common Stock 5,000 500,000 190,500 0.2 %

Roscoe Medical, Inc.

Healthcare Services

Second Lien Term Loan

11.25% Cash, 9/26/2019

$ 4,200,000 4,125,576 4,115,580 3.4 %

Smile Brands Group Inc. (d)

Healthcare Services

First Lien Term Loan

7.50% Cash, 8/16/2019

$ 4,455,000 4,385,708 4,232,250 3.5 %

Surgical Specialties Corporation (US), Inc. (d)

Healthcare Services First Lien Term Loan 7.25% Cash, 8/22/2018 $ 2,343,750 2,325,095 2,320,312 1.9 %

Zest Holdings, LLC (d)

Healthcare Services

First Lien Term Loan

6.50% Cash, 8/16/2020

$ 4,455,084 4,369,027 4,455,084 3.6 %

Total Healthcare Services 34,749,285 34,430,625 28.1 %

Distribution International, Inc. (d)

Manufacturing

First Lien Term Loan

7.50% Cash, 7/16/2019

$ 5,925,000 5,876,718 5,925,000 4.8 %

Total Manufacturing 5,876,718 5,925,000 4.8 %

HMN Holdco, LLC

Media

First Lien Term Loan

14.00% Cash, 5/16/2019

$ 9,438,047 9,267,197 9,343,666 7.6 %

HMN Holdco, LLC (g)

Media Warrants to Purchase Limited Liability Company Interests (Common) 57,872 394,108 0.3 %

HMN Holdco, LLC (g)

Media Warrants to Purchase Limited Liability Company Interests 8,139 106,214 0.1 %

Total Media 9,267,197 9,843,988 8.0 %

Elyria Foundry Company, L.L.C. (d), (g)

Metals

Senior Secured Note

17.00% (13.00% Cash/4.00% PIK), 1/31/2015

$ 8,859,616 8,859,614 6,020,268 4.9 %

Elyria Foundry Company, L.L.C. (d), (g)

Metals Warrants to Purchase Limited Liability Company Interests (2008) 7,000 20 0.0 %

Elyria Foundry Company, L.L.C. (d), (g)

Metals Warrants to Purchase Limited Liability Company Interests (2013) 18,227 0.0 %

Total Metals 8,859,634 6,020,268 4.9 %

Network Communications, Inc. (d), (g)

Publishing Common Stock 380,572 0.0 %

Network Communications, Inc. (d)

Publishing

Unsecured Notes

8.60% PIK, 1/14/2020

$ 2,657,971 2,299,254 1,559,269 1.3 %

Total Publishing 2,299,254 1,559,269 1.3 %

Censis Technologies, Inc.

Software

First Lien Term Loan B

11.00% Cash, 7/24/2019

$ 11,925,000 11,695,936 11,925,000 9.7 %

Censis Technologies, Inc. (g), (h)

Software Limited Partner Interests 999 999,000 999,000 0.8 %

Community Investors, Inc. (g)

Software Common Stock 1,282 1,282 1,602 0.0 %

Community Investors, Inc.

Software

First Lien, Last Out Term Loan

11.83% Cash, 9/30/2019

$ 12,000,000 12,000,000 12,000,000 9.8 %

Community Investors, Inc. (g)

Software Preferred Stock 63,463 149,138 79,329 0.1 %

Community Investors, Inc. (g)

Software Preferred Stock—A Shares 135,584 135,584 169,480 0.1 %

Finalsite Holdings, Inc.

Software

Second Lien Term Loan

10.25% Cash, 11/21/2019

$ 7,500,000 7,425,157 7,500,000 6.2 %

Identity Automation Systems (g)

Software Common Stock Class A Units 232,616 232,616 358,229 0.3 %

Identity Automation Systems

Software First Lien Term Loan 10.25% Cash, 8/25/2019 $ 4,500,000 4,456,885 4,500,000 3.7 %

Pen-Link, Ltd. (d)

Software Second Lien Term Loan 12.50% Cash, 5/26/2019 $ 11,500,000 11,302,271 11,500,000 9.5 %

Total Software 48,397,869 49,032,640 40.2 %

Advanced Air & Heat of Florida, LLC

Utilities First Lien Term Loan 10.00% Cash, 1/31/2019 $ 6,105,441 6,026,036 6,105,441 5.0 %

Total Utilities 6,026,036 6,105,441 5.0 %

Sub Total Non-control/Non-affiliated investments

222,452,952 221,740,190 181.3 %

6


Table of Contents

Control investments—15.9% (b)

Saratoga Investment Corp. CLO
2013-1, Ltd. (a), (d), (e), (f)

Structured Finance Securities Other/Structured Finance Securities 17.89%, 10/17/2023 $ 30,000,000 16,384,467 19,433,253 15.9 %

Sub Total Control investments

16,384,467 19,433,253 15.9 %

TOTAL INVESTMENTS—197.2% (b)

$ 238,837,419 $ 241,173,443 197.2 %

(a) Represents a non-qualifyng investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 8.1% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b) Percentages are based on net assets of $122,315,757 as of November 30, 2014.
(c) Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors. (see Note 3 to the consolidated financial statements).
(d) These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e) This investment does not have a stated interest rate that is payable thereon. As a result, the 17.89% interest rate in the table above represents the interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f) As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

Company

Purchases Redemptions Sales
(cost)
Interest
Income
Management
fee income
Net Realized
gains/(losses)
Net Unrealized
gain

Saratoga Investment Corp. CLO 2013-1, Ltd.

$ $ $ $ 1,996,010 $ 1,150,505 $ $ 3,048,786

(g) Non-income producing at November 30, 2014.
(h) Includes securities issued by an affiliate of the company.

7


Table of Contents

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 28, 2014

Company

Industry

Investment Interest Rate /
Maturity

Principal/
Number
of Shares
Cost Fair Value (c) % of
Net Assets

Non-control/Non-affiliated investments—162.1% (b)

PATS Aircraft, LLC

Aerospace Common Stock 51,813 $ 89,636 $ 89,636 0.1 %

PATS Aircraft, LLC

Aerospace First Lien Term Loan 8.50% Cash, 10/6/2016 $ 254,598 254,598 254,598 0.2 %

Total Aerospace 344,234 344,234 0.3 %

National Truck Protection Co., Inc. (d, g)

Automotive Aftermarket Common Stock 1,116 1,000,000 1,152,531 1.0 %

National Truck Protection Co., Inc. (d)

Automotive Aftermarket First Lien Term Loan 15.50% (13.50% Cash/2.00% PIK), 9/13/2018 $ 8,250,000 8,250,000 8,250,000 7.2 %

Take 5 Oil Change, L.L.C. (d, g)

Automotive Aftermarket Common Stock 7,128 712,800 1,217,747 1.1 %

Total Automotive Aftermarket 9,962,800 10,620,278 9.3 %

Legacy Cabinets Holdings (d, g)

Building Products Common Stock Voting A-1 2,535 220,900 552,351 0.5 %

Legacy Cabinets Holdings (d, g)

Building Products Common Stock Voting B-1 1,600 139,424 348,624 0.3 %

Total Building Products 360,324 900,975 0.8 %

ARSloane Acquistion, LLC

Business Services First Lien Term Loan 7.50% Cash, 10/1/2019 $ 997,500 988,200 1,004,981 0.9 %

BMC Software, Inc. (d)

Business Services First Lien Term Loan 5.00% Cash, 9/10/2020 $ 6,000,000 5,943,801 6,013,800 5.2 %

Dispensing Dynamics International (d)

Business Services Senior Secured Note 12.50% Cash, 1/1/2018 $ 7,000,000 6,882,278 7,525,000 6.5 %

Easy Ice, LLC (d)

Business Services First Lien Term Loan 14.00% (11.00% Cash/3.00% PIK), 3/29/2018 $ 7,507,024 7,387,970 7,507,024 6.5 %

Emily Street Enterprises, L.L.C. (d)

Business Services Senior Secured Note 12.00% (11.00% Cash/1.00% PIK), 12/28/2017 $ 5,767,983 5,680,703 5,767,983 5.0 %

Emily Street Enterprises, L.L.C. (d, g)

Business Services Warrant Membership Interests 49,318 400,000 601,679 0.5 %

Help/Systems Holdings, Inc.(Help/Systems, LLC) (d)

Business Services First Lien Term Loan 5.50% Cash, 6/28/2019 $ 3,990,000 3,954,385 3,960,075 3.5 %

Help/Systems Holdings, Inc.(Help/Systems, LLC) (d)

Business Services Second Lien Term Loan 9.50% Cash, 6/28/2020 $ 2,000,000 1,972,758 2,000,000 1.7 %

Knowland Technology Holdings, L.L.C. (d)

Business Services First Lien Term Loan 11.00% Cash, 11/29/2017 $ 6,200,000 6,107,034 6,200,000 5.4 %

Trinet HR Corporation (SOI Holdings, Inc.) (d)

Business Services First Lien Term Loan 5.00% Cash, 8/20/2020 $ 4,987,500 4,941,335 5,018,921 4.4 %

Trinet HR Corporation (SOI Holdings, Inc.) (d)

Business Services Second Lien Term Loan 8.75% Cash, 2/20/2021 $ 2,500,000 2,453,145 2,518,750 2.2 %

Vector Controls Holding Co., LLC (d)

Business Services First Lien Term Loan, 14.00% (12.00% Cash/2.00% PIK), 3/6/2018 $ 9,261,074 9,115,415 9,075,853 7.9 %

Vector Controls Holding Co., LLC (d, g)

Business Services Warrants to Purchase Limited Liability Company Interests 101 136,217 0.1 %

Total Business Services 55,827,024 57,330,283 49.8 %

Targus Group International, Inc. (d)

Consumer Products First Lien Term Loan 11.00% Cash, 5/24/2016 $ 3,738,369 3,704,766 3,663,602 3.2 %

Targus Holdings, Inc. (d, g)

Consumer Products Common Stock 62,413 566,765 730,232 0.6 %

Targus Holdings, Inc. (d)

Consumer Products Unsecured Note 10.00% PIK, 6/14/2019 $ 2,054,158 2,054,158 1,387,848 1.2 %

Targus Holdings, Inc. (d)

Consumer Products Unsecured Note 16.00% Cash, 10/26/2018 $ 384,577 379,471 336,505 0.3 %

Total Consumer Products 6,705,160 6,118,187 5.3 %

Avionte Holdings, LLC

Consumer Services Common Stock $ 100,000 100,000 100,000 0.1 %

Avionte Holdings, LLC

Consumer Services First Lien Term Loan 9.75% Cash, 1/8/2019 $ 3,000,000 2,940,000 3,000,000 2.6 %

CFF Acquisition L.L.C. (d)

Consumer Services First Lien Term Loan 7.50% Cash, 7/31/2015 $ 1,319,891 1,273,596 1,319,891 1.1 %

Expedited Travel L.L.C. (d)

Consumer Services First Lien Term Loan 9.00% Cash, 12/28/2017 $ 4,580,000 4,501,104 4,580,000 4.0 %

PrePaid Legal Services, Inc. (d)

Consumer Services First Lien Term Loan 6.25% Cash, 12/31/2016 $ 4,274,194 4,236,035 4,247,694 3.7 %

PrePaid Legal Services, Inc. (d)

Consumer Services Second Lien Term Loan 9.75% Cash, 7/1/2020 $ 5,000,000 4,931,888 5,044,000 4.4 %

Total Consumer Services 17,982,623 18,291,585 15.9 %

8


Table of Contents

M/C Acquisition Corp., L.L.C. (d, g)

Education Class A Common Stock 544,761 30,241 0.0 %

M/C Acquisition Corp., L.L.C. (d)

Education First Lien Term Loan 1.00% Cash, 3/13/14 $ 2,512,184 1,358,250 90,128 0.1 %

Total Education 1,388,491 90,128 0.1 %

Group Dekko, Inc. (d)

Electronics Second Lien Term Loan 11.00% (10.00% Cash/1.00% PIK), 5/1/2016 $ 6,901,547 6,901,547 6,741,431 5.9 %

Total Electronics 6,901,547 6,741,431 5.9 %

USS Parent Holding Corp. (d, g)

Environmental Non Voting Common Stock 765 133,002 220,992 0.2 %

USS Parent Holding Corp. (d, g)

Environmental Voting Common Stock 17,396 3,025,798 5,027,574 4.4 %

Total Environmental 3,158,800 5,248,566 4.6 %

DS Waters of America, Inc. (d)

Food and
Beverage
First Lien Term Loan 5.25% Cash, 8/30/2020 $ 2,493,750 2,470,506 2,531,156 2.2 %

HOA Restaurant Group, L.L.C. (d)

Food and
Beverage
Senior Secured Note 11.25% Cash, 4/1/2017 $ 4,000,000 3,918,437 4,240,000 3.7 %

TB Corp. (d)

Food and
Beverage
First Lien Term Loan 5.75% Cash, 6/19/2018 $ 5,101,971 5,082,013 5,127,481 4.5 %

TB Corp. (d)

Food and
Beverage
Unsecured Note 13.50% (12.00% Cash/1.50% PIK), 12/20/2018 $ 2,543,154 2,513,130 2,555,870 2.2 %

TM Restaurant Group L.L.C. (d)

Food and
Beverage
First Lien Term Loan 7.75% Cash, 7/16/2017 $ 2,845,690 2,831,271 2,831,462 2.5 %

Total Food and Beverage 16,815,357 17,285,969 15.1 %

Bristol Hospice, LLC

Healthcare
Services
Senior Secured Note 11.00%(10.00% Cash/1.00% PIK), 11/29/2018 $ 5,509,782 5,405,325 5,509,782 4.8 %

Oceans Acquisition, Inc. (d)

Healthcare
Services
First Lien Term A Loan 10.75% Cash, 12/27/2017 $ 6,373,113 6,273,020 6,373,113 5.6 %

Oceans Acquisition, Inc. (d)

Healthcare
Services
First Lien Term B Loan 10.75% Cash, 12/27/2017 $ 500,000 490,224 500,000 0.4 %

Smile Brands Group Inc. (d)

Healthcare
Services
First Lien Term Loan 7.50% Cash, 8/16/2019 $ 4,488,750 4,406,559 4,488,750 3.9 %

Surgical Specialties Corporation (US), Inc. (d)

Healthcare
Services
First Lien Term Loan 7.25% Cash, 8/22/2018 $ 2,437,500 2,415,591 2,449,688 2.1 %

Zest Holdings, LLC (d)

Healthcare
Services
First Lien Term Loan 6.50% Cash, 8/16/2020 $ 4,488,750 4,405,073 4,488,750 3.9 %

Total Healthcare Services 23,395,792 23,810,083 20.7 %

McMillin Companies L.L.C. (d, g, h)

Homebuilding Senior Secured Note 0% Cash, 12/31/2013 $ 550,000 558,434 344,355 0.3 %

Total Homebuilding 558,434 344,355 0.3 %

Distribution International, Inc.. (d)

Manufacturing First Lien Term Loan 7.50% Cash, 7/16/2019 $ 5,970,000 5,916,094 5,970,000 5.2 %

Total Manufacturing 5,916,094 5,970,000 5.2 %

Elyria Foundry Company, L.L.C. (d)

Metals Senior Secured Note 17.00% (13.00% Cash/4.00% PIK), 9/14/2014 $ 8,859,614 8,859,614 6,644,711 5.8 %

Elyria Foundry Company, L.L.C. (d, g)

Metals Warrants to Purchase Limited Liability Company Interests (2008) 7,000 20 0.0 %

Elyria Foundry Company, L.L.C. (d, g)

Metals Warrants to Purchase Limited Liability Company Interests (2013) 18,227 0.0 %

Total Metals 8,859,634 6,644,711 5.8 %

Network Communications, Inc. (d, g)

Publishing Common Stock 380,572 0.0 %

Network Communications, Inc. (d)

Publishing Unsecured Notes 8.60% PIK, 1/14/2020 $ 2,601,736 2,202,168 1,190,888 1.0 %

Total Publishing 2,202,168 1,190,888 1.0 %

Community Investors, Inc. (d, g)

Software Common Stock 1,282 1,282 1,449 0.0 %

Community Investors, Inc. (d)

Software First Lien Term Loan 9.75% Cash, 5/9/2018 $ 6,983,333 6,863,915 6,983,333 6.1 %

Community Investors, Inc. (d)

Software Revolver $ 166,667 0.0 %

Community Investors, Inc. (d, g)

Software Preferred Stock 135,584 135,584 153,210 0.1 %

Pen-Link, Ltd.

Software Second Lien Term Loan 12.50% Cash, 5/26/2019 $ 11,500,000 11,280,887 11,500,000 10.0 %

Total Software 18,281,668 18,637,992 16.2 %

9


Table of Contents

Advanced Air & Heat of Florida, LLC

Utilities First Lien Term Loan 10.00% Cash, 1/31/2019 $ 6,705,441 6,606,457 6,705,441 5.8 %

Total Utilities 6,606,457 6,705,441 5.8 %

Sub Total Non-control/Non-affiliated investments

185,266,607 186,275,106 162.1 %

Control investments—17.0% (b)

Saratoga Investment Corp. CLO 2013-1, Ltd. (a) (d), (e), (f)

Structured Finance Securities Other/Structured Finance Securities 15.16%, 10/17/2023 $ 30,000,000 16,555,808 19,569,596 17.0 %

Sub Total Control investments

16,555,808 19,569,596 17.0 %

TOTAL INVESTMENTS—179.1% (b)

$ 201,822,415 $ 205,844,702 179.1 %

(a) Represents a non-qualifyng investment as defined under Section 55 (a) of the Investment Company Act of 1940, as amended. Non-qualifying assets represent 8.5% of the Company’s portfolio at fair value. As a BDC, the Company can only invest 30% of its portfolio in non-qualifying assets.
(b) Percentages are based on net assets of $114,924,018 as of February 28, 2014.
(c) Because there is no readily available market value for these investments, the fair value of these investments is approved in good faith by our board of directors. (see Note 3 to the consolidated financial statements).
(d) These securities are pledged as collateral under a senior secured revolving credit facility (see Note 6 to the consolidated financial statements).
(e) This investment does not have a stated interest rate that is payable thereon. As a result, the 15.16% interest rate in the table above represents the interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f) As defined in the Investment Company Act, we “Control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the period in which the issuer was both an Affiliate and a portfolio company that we Control are as follows:

Company

Purchases Redemptions Sales
(cost)
Interest
Income
Management
fee income
Net Realized
gains/(losses)
Net Unrealized
gains/(losses)

Saratoga Investment Corp. CLO 2013-1, Ltd.

$ $ $ $ 3,410,868 $ 1,775,141 $ $ 3,013,788

(g) Non-income producing at February 28, 2014.
(h) In connection with the restructuring of this investment, the Company agreed to forego the receipt of any interest payments thereon.

10


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Changes in Net Assets

(unaudited)

For the nine months ended
November 30, 2014
For the nine months ended
November 30, 2013

INCREASE FROM OPERATIONS:

Net investment income

$ 6,842,936 $ 7,639,588

Net realized gain from investments

3,203,399 1,157,824

Net unrealized depreciation on investments

(1,686,263 ) (3,770,968 )

Net increase in net assets from operations

8,360,072 5,026,444

DECREASE FROM SHAREHOLDER DISTRIBUTIONS:

Distributions declared

(968,333 ) (12,534,807 )

Net decrease in net assets from shareholder distributions

(968,333 ) (12,534,807 )

CAPITAL SHARE TRANSACTIONS:

Stock dividend distribution

10,027,695

Net increase in net assets from capital share transactions

10,027,695

Total increase in net assets

7,391,739 2,519,332

Net assets at beginning of period

114,924,018 108,686,761

Net assets at end of period

$ 122,315,757 $ 111,206,093

Net asset value per common share

$ 22.74 $ 20.67

Common shares outstanding at end of period

5,379,616 5,379,616

Distribution in excess of net investment income

$ (23,752,974 ) $ (29,418,170 )

See accompanying notes to consolidated financial statements.

11


Table of Contents

Saratoga Investment Corp.

Consolidated Statements of Cash Flows

(unaudited)

For the nine months ended
November 30, 2014
For the nine months ended
November 30, 2013

Operating activities

NET INCREASE IN NET ASSETS FROM OPERATIONS

$ 8,360,072 $ 5,026,444

ADJUSTMENTS TO RECONCILE NET INCREASE IN NET ASSETS FROM OPERATIONS TO NET CASH USED BY OPERATING ACTIVITIES:

Paid-in-kind interest income

(566,776 ) (634,408 )

Net accretion of discount on investments

(435,222 ) (543,999 )

Amortization of deferred debt financing costs

726,579 660,568

Net realized gain from investments

(3,203,399 ) (1,157,824 )

Net unrealized depreciation on investments

1,686,263 3,770,968

Proceeds from sale and redemption of investments

51,175,739 64,989,332

Purchase of investments

(83,985,346 ) (110,122,464 )

(Increase) decrease in operating assets:

Cash and cash equivalents, reserve accounts

(7,444,962 ) 10,487,010

Interest receivable

(599,123 ) 138,220

Due from manager

(4,929 )

Management fee receivable

(28,128 ) 49,171

Other assets

5,878 (16,190 )

Receivable from unsettled trades

1,817,074

Increase (decrease) in operating liabilities:

Management and incentive fees payable

694,274 (922,261 )

Accounts payable and accrued expenses

(274,003 ) (53,553 )

Interest and debt fees payable

(147,834 ) 256,537

Due to manager

(60,721 ) 50,570

NET CASH USED BY OPERATING ACTIVITIES

(34,096,709 ) (26,209,734 )

Financing activities

Borrowings on debt

47,600,000 8,000,000

Paydowns on debt

(13,700,000 ) (24,300,000 )

Issuance of notes

48,300,000

Debt financing cost

(1,639,800 ) (2,579,308 )

Payments of cash dividends

(648,144 )

NET CASH PROVIDED BY FINANCING ACTIVITIES

31,612,056 29,420,692

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

(2,484,653 ) 3,210,958

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD

3,293,898 149,025

CASH AND CASH EQUIVALENTS, END OF PERIOD

$ 809,245 $ 3,359,983

Supplemental information:

Interest paid during the period

$ 4,887,477 $ 3,425,552

Supplemental non-cash information:

Paid-in-kind interest income

$ 566,776 $ 634,408

Net accretion of discount on investments

$ 435,222 $ 543,999

Amortization of deferred debt financing costs

$ 726,579 $ 660,568

Stock dividend distribution

$ $ 10,027,695

Cash dividend payable

$ $ 2,507,112

See accompanying notes to consolidated financial statements.

12


Table of Contents

SARATOGA INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

November 30, 2014

(unaudited)

Note 1. Organization and Basis of Presentation

Saratoga Investment Corp. (the “Company”, “we”, “our” and “us”) is a non-diversified closed end management investment company incorporated in Maryland that has elected to be treated and is regulated as a business development company (“BDC”) under the Investment Company Act of 1940 (the “1940 Act”). We commenced operations on March 23, 2007 as GSC Investment Corp. and completed our initial public offering (“IPO”) on March 28, 2007. We have elected to be treated as a regulated investment company (“RIC”) under subchapter M of the Internal Revenue Code (the “Code”). We expect to continue to qualify and to elect to be treated for tax purposes as a RIC. Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments.

GSC Investment, LLC (the “LLC”) was organized in May 2006 as a Maryland limited liability company. As of February 28, 2007, the LLC had not yet commenced its operations and investment activities.

On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC’s limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.

On July 30, 2010, the Company changed its name from “GSC Investment Corp.” to “Saratoga Investment Corp.”.

We are externally managed and advised by our investment adviser, Saratoga Investment Advisors, LLC (the “Manager”), pursuant an investment advisory and management agreement dated July 30, 2010 (the “Management Agreement”). Prior to July 30, 2010, we were managed and advised by GSCP (NJ), L.P.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received a Small Business Investment Company (“SBIC”) license from the Small Business Administration (“SBA”).

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”) and include the accounts of the Company its special purpose financing subsidiary, Saratoga Investment Funding, LLC (previously known as GSC Investment Funding LLC) and SBIC LP. All intercompany accounts and transactions have been eliminated in consolidation. All references made to the “Company,” “we,” and “us” herein include Saratoga Investment Corp. and its consolidated subsidiaries, except as stated otherwise.

Note 2. Summary of Significant Accounting Policies

Use of Estimates in the Preparation of Financial Statements

The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.

Cash and Cash Equivalents

Cash and cash equivalents include short-term, liquid investments in a money market fund. Cash and cash equivalents are carried at cost which approximates fair value. Per section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another registered investment company such as, a money market fund if such investment would cause the Company to exceed any of the following limitations:

we were to own more than 3.0% of the total outstanding voting stock of the money market fund;

we were to hold securities in the money market fund having an aggregate value in excess of 5.0% of the value of our total assets; or

we were to hold securities in money market funds and other registered investment companies and BDCs having an aggregate value in excess of 10.0% of the value of our total assets.

13


Table of Contents

Cash and Cash Equivalents, Reserve Accounts

Cash and cash equivalents, reserve accounts include amounts held in designated bank accounts in the form of cash and short-term liquid investments in money market funds representing payments received on secured investments or other reserved amounts associated with our $45.0 million senior secured revolving credit facility with Madison Capital Funding LLC. The Company is required to use these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the senior secured revolving credit facility.

Investment Classification

The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “Control Investments” are defined as investments in companies in which we own more than 25.0% of the voting securities or maintain greater than 50.0% of the board representation. Under the 1940 Act, “Affiliated Investments” are defined as those non-control investments in companies in which we own between 5.0% and 25.0% of the voting securities. Under the 1940 Act, “Non-affiliated Investments” are defined as investments that are neither Control Investments nor Affiliated Investments.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the statement of assets and liabilities date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from our Manager, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

Each investment is initially valued by the responsible investment professionals of our Manager and preliminary valuation conclusions are documented and discussed with the senior management of our Manager; and

An independent valuation firm engaged by our board of directors reviews approximately one quarter of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least annually.

In addition, all our investments are subject to the following valuation process:

The audit committee of our board of directors reviews each preliminary valuation and our Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of our Manager, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

14


Table of Contents

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. Our net asset value could be materially affected if the determinations regarding the fair value of our investments were materially higher or lower than the values that we ultimately realize upon the disposal of such investments.

Investment Transactions and Income Recognition

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets , (“ASC 325-40”), based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Other Income

Other income includes dividends received, origination fees, structuring fees and advisory fees, and is recorded in income when earned.

Paid-in-Kind Interest

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Deferred Debt Financing Costs

Financing costs incurred in connection with our credit facility are deferred and amortized using the straight line method over the life of their respective facilities. Financing costs incurred in connection with our SBA debentures are deferred and amortized using the effective yield method over the life of the debentures.

Contingencies

In the ordinary course of its business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management feels that the likelihood of such an event is remote.

15


Table of Contents

In the ordinary course of business, the Company may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Company.

Income Taxes

The Company has filed an election to be treated for tax purposes as a RIC under Subchapter M of the Code and, among other things, intends to make the requisite distributions to its stockholders which will relieve the Company from federal income taxes. Therefore, no provision has been recorded for federal income taxes.

In order to qualify as a RIC, among other requirements, the Company is required to timely distribute to its stockholders at least 90.0% of its investment company taxable income, as defined by the Code, for each fiscal tax year. The Company will be subject to a nondeductible U.S. federal excise tax of 4.0% on undistributed income if it does not distribute at least 98.0% of its ordinary income in any calendar year and 98.2% of its capital gain net income for each one-year period ending on October 31.

Depending on the level of taxable income earned in a tax year, the Company may choose to carry forward taxable income in excess of current year dividend distributions into the next tax year and pay a 4.0% excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year dividend distributions for excise tax purposes, the Company accrues excise tax, if any, on estimated excess taxable income as taxable income is earned.

In accordance with certain applicable Treasury regulations and private letter rulings issued by the Internal Revenue Service, a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution. If too many stockholders elect to receive cash, each stockholder electing to receive cash will receive a pro rata amount of cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20.0% of his or her entire distribution in cash. If these and certain other requirements are met, for U.S federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

ASC 740, Income Taxes , (“ASC 740”), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense in the consolidated statements of operations. During the fiscal year ended February 28, 2014, the Company did not incur any interest or penalties. Although we file federal and state tax returns, our major tax jurisdiction is federal. The 2011, 2012 and 2013 federal tax years for the Company remain subject to examination by the IRS. As of November 30, 2014 and February 28, 2014, there were no uncertain tax positions.

Dividends

Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain such capital gains for reinvestment.

We have adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare, a cash dividend, then our stockholders who have not “opted out” of the DRIP by the dividend record date will have their cash dividends automatically reinvested into additional shares of our common stock, rather than receiving the cash dividends. We have the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator.

Capital Gains Incentive Fee

The Company records an expense accrual on the consolidated statements of operations, relating to the capital gains incentive fee payable on the consolidated statements of assets and liabilities, by the Company to its investment adviser when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

16


Table of Contents

New Accounting Pronouncements

In June 2014, the FASB issued ASU 2014-11, Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures, (“ASU 2014-11”). ASU 2014-11 makes limited changes to the accounting for repurchase agreements, clarifies when repurchase agreements and securities lending transactions should be accounted for as secured borrowings, and requires additional disclosures regarding these types of transactions. The guidance is effective for fiscal years beginning on or after December 15, 2014, and for interim periods within those fiscal years. Management is currently evaluating the impact these changes will have on the Company’s consolidated financial statement disclosures.

Risk Management

In the ordinary course of its business, the Company manages a variety of risks, including market risk and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount.

The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.

The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

Note 3. Investments

As noted above, the Company values all investments in accordance with ASC 820. ASC 820 requires enhanced disclosures about assets and liabilities that are measured and reported at fair value. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

Level 2—Valuations based on inputs other than quoted prices in active markets, which are either directly or indirectly observable.

Level 3—Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The inputs used in the determination of fair value may require significant management judgment or estimation. Such information may be the result of consensus pricing information or broker quotes which include a disclaimer that the broker would not be held to such a price in an actual transaction. The non-binding nature of consensus pricing and/or quotes accompanied by disclaimer would result in classification as Level 3 asset, assuming no additional corroborating evidence.

In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 and the 1940 Act (see Note 2). Consistent with our Company’s valuation policy, we evaluate the source of inputs, including any markets in which our investments are trading, in determining fair value.

17


Table of Contents

The following table presents fair value measurements of investments, by major class, as of November 30, 2014 (dollars in thousands), according to the fair value hierarchy:

Fair Value Measurements
Level 1 Level 2 Level 3 Total

Syndicated loans

$ $ $ 24,523 $ 24,523

First lien term loans

120,627 120,627

Second lien term loans

36,601 36,601

Senior secured notes

24,791 24,791

Unsecured notes

5,973 5,973

Structured finance securities

19,433 19,433

Equity interest

9,225 9,225

Total

$ $ $ 241,173 $ 241,173

The following table presents fair value measurements of investments, by major class, as of February 28, 2014 (dollars in thousands), according to the fair value hierarchy:

Fair Value Measurements
Level 1 Level 2 Level 3 Total

Syndicated loans

$ $ $ 32,390 $ 32,390

First lien term loans

80,246 80,246

Second lien term loans

27,804 27,804

Senior secured notes

30,032 30,032

Unsecured notes

5,471 5,471

Structured finance securities

19,570 19,570

Equity interest

10,332 10,332

Total

$ $ $ 205,845 $ 205,845

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended November 30, 2014 (dollars in thousands):

Syndicated
loans
First lien
term loans
Second lien
term loans
Senior
secured
notes
Unsecured
notes
Structured
finance
securities
Common
stock/
equities
Total

Balance as of February 28, 2014

$ 32,390 $ 80,246 $ 27,804 $ 30,032 $ 5,471 $ 19,570 $ 10,332 $ 205,845

Net unrealized gains (losses)

(485 ) 92 (379 ) (796 ) 355 35 (508 ) (1,686 )

Purchases and other adjustments to cost

44 62,812 18,630 91 147 3,263 84,987

Sales and redemptions

(7,462 ) (23,027 ) (9,500 ) (4,788 ) (172 ) (6,227 ) (51,176 )

Net realized gains from investments

36 504 46 252 2,365 3,203

Balance as of November 30, 2014

$ 24,523 $ 120,627 $ 36,601 $ 24,791 $ 5,973 $ 19,433 $ 9,225 $ 241,173

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended November 30, 2013 (dollars in thousands):

Syndicated
loans
First
lien term
loans
Second lien
term loans
Senior
secured
notes
Unsecured
notes
Structured
finance
securities
Common
stock/
equities
Total

Balance as of February 28, 2013

$ $ 83,792 $ 9,571 $ 23,305 $ 4,874 $ 25,517 $ 8,021 $ 155,080

Net unrealized gains (losses)

396 (452 ) 120 (23 ) 339 (4,109 ) (42 ) (3,771 )

Purchases and other adjustments to cost

37,031 38,305 20,693 14,366 166 740 111,301

Sales and redemptions

(46 ) (51,667 ) (3,031 ) (7,728 ) (2,389 ) (128 ) (64,989 )

Net realized gains from investments

659 371 128 1,158

Balance as of November 30, 2013

$ 37,381 $ 70,637 $ 27,724 $ 29,920 $ 5,379 $ 19,019 $ 8,719 $ 198,779

18


Table of Contents

Purchases and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK.

Sales and redemptions represent net proceeds received from investments sold, and principal paydowns received, during the period.

The net change in unrealized gain/(loss) for the nine months ended November 30, 2014 and 2013, on investments held as of November 30, 2014 and 2013, was $573,734 and $(3,890,205), respectively, and is included in net unrealized appreciation (depreciation) on investments in the consolidated statements of operations.

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of November 30, 2014 were as follows (dollars in thousands):

Fair Value Valuation Technique Unobservable Input Range Weighted
Average Yield

Syndicated loans

$ 24,523 Market Comparables Third-Party Bid 95.0 - 100.0 98.6%

First lien term loans

120,627 Market Comparables Market Yield (%) 5.5% - 15.6% 10.9%
EBITDA Multiples (x) 3.0x 3.0x
Third-Party Bid 83.7 - 100.0 92.3%

Second lien term loans

36,601 Market Comparables Market Yield (%) 9.8% - 16.7% 12.3%
Third-Party Bid 99.5 — 100.5 100.2%

Senior secured notes

24,791 Market Comparables Market Yield (%) 11.0% - 12.0% 11.5%
EBITDA Multiples (x) 5.0x 5.0x
Third-Party Bid 107.0 107.0%

Unsecured notes

5,973 Market Comparables Market Yield (%) 13.2% - 21.2% 17.0%

Structured finance securities

19,433 Discounted Cash Flow Discount Rate (%) 10.0% 10.0%

Equity interests

9,225 Market Comparables EBITDA Multiples (x) 2.2x — 11.1x 7.1x

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 28, 2014 were as follows (dollars in thousands):

Fair Value Valuation Technique Unobservable Input Range Weighted
Average Yield

Syndicated loans

$ 32,390 Market Comparables Third-Party Bid 99.5 - 100.6 100.1%

First lien term loans

80,246 Market Comparables Market Yield (%) 5.1% - 15.5% 10.4%
EBITDA Multiples (x) 3.0x 3.0x
Third-Party Bid 83.3 - 101.5 97.0%

Second lien term loans

27,804 Market Comparables Market Yield (%) 9.6% - 12.5% 11.7%
Third-Party Bid 100.0 — 101.8 101.1%

Senior secured notes

30,032 Market Comparables Market Yield (%) 11.0% - 42.5% 12.4%
EBITDA Multiples (x) 5.0x 5.0x
Third-Party Bid 106.0 - 107.5 107.0%

Unsecured notes

5,471 Market Comparables Market Yield (%) 12.8% - 20.3% 16.5%

Structured finance securities

19,570 Discounted Cash Flow Discount Rate (%) 9.0% 9.0%

Equity interests

10,332 Market Comparables EBITDA Multiples (x) 6.3x — 12.0x 7.8x

19


Table of Contents

For investments utilizing a market comparables valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement, and a significant increase (decrease) in any of the EBITDA valuation multiples, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a discounted cash flow valuation technique, a significant increase (decrease) in the discount rate, in isolation, would result in a significantly lower (higher) fair value measurement.

The composition of the Company’s investments as of November 30, 2014, at amortized cost and fair value were as follows (dollars in thousands):

Investments at
Amortized Cost
Amortized Cost
Percentage of
Total Portfolio
Investments at
Fair Value
Fair Value
Percentage of
Total Portfolio

Syndicated loans

$ 24,602 10.3 % $ 24,523 10.2 %

First lien term loans

121,024 50.7 120,627 50.0

Second lien term loans

36,716 15.4 36,601 15.2

Senior secured notes

26,859 11.2 24,791 10.3

Unsecured notes

7,297 3.0 5,973 2.5

Structured finance securities

16,384 6.9 19,433 8.0

Equity interest

5,955 2.5 9,225 3.8

Total

$ 238,837 100.0 % $ 241,173 100.0 %

The composition of the Company’s investments as of February 28, 2014, at amortized cost and fair value were as follows (dollars in thousands):

Investments at
Amortized Cost
Amortized Cost
Percentage of
Total Portfolio
Investments at
Fair Value
Fair Value
Percentage of
Total Portfolio

Syndicated loans

$ 31,983 15.8 % $ 32,390 15.7 %

First lien term loans

80,734 40.0 80,246 39.0

Second lien term loans

27,540 13.6 27,804 13.5

Senior secured notes

31,304 15.6 30,032 14.6

Unsecured notes

7,149 3.5 5,471 2.7

Structured finance securities

16,556 8.2 19,570 9.5

Equity interest

6,556 3.3 10,332 5.0

Total

$ 201,822 100.0 % $ 205,845 100.0 %

For loans and debt securities for which market quotations are not available, we determine their fair value based on third party indicative broker quotes, where available, or the assumptions that a hypothetical market participant would use to value the security in a current hypothetical sale using a market yield valuation methodology. In applying the market yield valuation methodology, we determine the fair value based on such factors as market participant assumptions including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in our judgment, the market yield methodology is not sufficient or appropriate, we may use additional methodologies such as an asset liquidation or expected recovery model.

For equity securities of portfolio companies and partnership interests, we determine the fair value based on the market approach with value then attributed to equity or equity like securities using the enterprise value waterfall valuation methodology. Under the enterprise value waterfall valuation methodology, we determine the enterprise fair value of the portfolio company and then waterfall the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, we weigh some or all of the traditional market valuation methods and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The methodologies for performing

20


Table of Contents

investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, we may estimate the liquidation or collateral value of the portfolio company’s assets and liabilities. We also take into account historical and anticipated financial results.

Our investment in Saratoga CLO is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by our Manager and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO at November 30, 2014. The significant inputs for the valuation model include:

Default rates: 2.0%

Recovery rates: 35-75%

Prepayment rate: 25.0%

Reinvestment rate / price: L+375bps / $99.75

The Company and SBIC are both considered to be investment companies for financial reporting purposes and have applied the guidance in Topic 946, “Financial Services — Investment Companies”. There have been no changes to the Company or SBIC’s status as investment companies during the quarterly period ended November 30, 2014.

Note 4. Investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”)

On January 22, 2008, we invested $30.0 million in all of the outstanding subordinated notes of GSC Investment Corp. CLO 2007, Ltd., a collateralized loan obligation fund managed by us that invests primarily in senior secured loans. Additionally, we entered into a collateral management agreement with GSC Investment Corp. CLO 2007, Ltd. pursuant to which we act as collateral manager to it. The Saratoga CLO was refinanced in October 2013 and its reinvestment period ends in October 2016. The Saratoga CLO remains 100% owned and managed by Saratoga Investment Corp. We receive a base management fee of 0.25% and a subordinated management fee of 0.25% of the Fee Basis Amount at the beginning of the Collection Period, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of the remaining interest proceeds and principal proceeds, if any, after the subordinated notes have realized the incentive management fee target return of 12.0%, in accordance with the Priority of Payments after making the prior distributions on the relevant payment date. For the three months ended November 30, 2014 and November 30, 2013, we accrued $0.4 million and $0.4 million in management fee income, respectively, and $0.7 million and $0.6 million in interest income, respectively, from Saratoga CLO. For the nine months ended November 30, 2014 and November 30, 2013, we accrued $1.2 million and $1.4 million in management fee income, respectively, and $2.0 million and $2.8 million in interest income, respectively, from Saratoga CLO. We did not accrue any amounts related to the incentive management fee as the 12.0% hurdle rate has not yet been achieved.

At November 30, 2014, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $19.4 million. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. At November 30, 2014, Saratoga CLO had investments with a principal balance of $302.6 million and a weighted average spread over LIBOR of 4.2%, and had debt with a principal balance of $282.4 million with a weighted average spread over LIBOR of 1.8%. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. At November 30, 2014, the total “spread”, or projected future cash flows of the subordinated notes, over the life of Saratoga CLO was $23.7 million, which had a present value of approximately $19.8 million, using a 10.0% discount rate.

Below is certain financial information from the separate unaudited financial statements of Saratoga CLO as of November 30, 2014 and February 28, 2014, pursuant to Rule 3-09 of SEC rules Regulation S-X, and for the three and nine months ended November 30, 2014 and November 30, 2013.

21


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Assets and Liabilities

As of
November 30, 2014 February 28, 2014
(unaudited)

ASSETS

Investments

Fair value loans (amortized cost of $300,731,616 and $299,137,566, respectively)

$ 297,038,596 $ 300,491,077

Total investments at fair value (amortized cost of $300,731,616 and $299,137,566, respectively)

297,038,596 300,491,077

Cash and cash equivalents

1,942,404 8,018,933

Receivable from open trades

6,091,525 1,801,266

Interest receivable

1,437,136 1,450,952

Deferred debt financing costs, net

1,997,854 2,166,633

Other assets

91,335 91,336

Total assets

$ 308,598,850 $ 314,020,197

LIABILITIES

Interest payable

$ 666,488 $ 622,476

Payable from open trades

8,536,209 9,445,000

Accrued base management fee

89,117 75,053

Accrued subordinated management fee

89,117 75,053

Class X Notes - SIC CLO 2013-1, Ltd.

1,666,666

Class A-1 Notes - SIC CLO 2013-1, Ltd.

170,000,000 170,000,000

Discount on Class A-1 Notes - SIC CLO 2013-1, Ltd.

(1,539,214 ) (1,671,864 )

Class A-2 Notes - SIC CLO 2013-1, Ltd.

20,000,000 20,000,000

Discount on Class A-2 Notes - SIC CLO 2013-1, Ltd.

(159,550 ) (173,300 )

Class B Notes - SIC CLO 2013-1, Ltd.

44,800,000 44,800,000

Discount on Class B Notes - SIC CLO 2013-1, Ltd.

(1,036,437 ) (1,125,757 )

Class C Notes - SIC CLO 2013-1, Ltd.

16,000,000 16,000,000

Discount on Class C Notes - SIC CLO 2013-1, Ltd.

(645,291 ) (700,902 )

Class D Notes - SIC CLO 2013-1, Ltd.

14,000,000 14,000,000

Discount on Class D Notes - SIC CLO 2013-1, Ltd.

(837,638 ) (909,825 )

Class E Notes - SIC CLO 2013-1, Ltd.

13,100,000 13,100,000

Discount on Class E Notes - SIC CLO 2013-1, Ltd.

(1,579,190 ) (1,715,285 )

Class F Notes - SIC CLO 2013-1, Ltd.

4,500,000 4,500,000

Discount on Class F Notes - SIC CLO 2013-1, Ltd.

(574,380 ) (623,880 )

Subordinated Notes

30,000,000 30,000,000

Total liabilities

$ 315,409,231 $ 317,363,435

Commitments and contingencies

NET ASSETS

Ordinary equity, par value $1.00, 250 ordinary shares authorized, 250 and 250 issued and outstanding, respectively

$ 250 $ 250

Accumulated gain/(loss)

(3,343,489 ) 838,567

Net loss

(3,467,142 ) (4,182,055 )

Total net assets

(6,810,381 ) (3,343,238 )

Total liabilities and net assets

$ 308,598,850 $ 314,020,197

22


Table of Contents

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Operations

(unaudited)

For the three months ended
November 30
For the nine months ended
November 30
2014 2013 2014 2013

INVESTMENT INCOME

Interest from investments

$ 3,353,937 $ 3,552,429 $ 9,834,775 $ 12,160,257

Interest from cash and cash equivalents

344 2,030 1,182 6,481

Other income

55,362 214,092 196,292 891,358

Total investment income

3,409,643 3,768,551 10,032,249 13,058,096

EXPENSES

Interest expense

2,831,770 6,906,431 6,955,909 9,944,427

Professional fees

43,547 62,452 137,907 387,380

Miscellaneous fee expense

6,734 4,198 33,130 164,989

Base management fee

191,505 134,244 575,252 330,012

Subordinated management fee

191,505 286,953 575,252 1,070,026

Trustee expenses

36,314 21,012 90,242 69,383

Amortization expense

237,966 3,692,220 717,892 4,201,074

Total expenses

3,539,341 11,107,510 9,085,584 16,167,291

NET INVESTMENT INCOME (LOSS)

(129,698 ) (7,338,959 ) 946,665 (3,109,195 )

REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS:

Net realized gain/(loss) on investments

104,158 (9,292,595 ) 632,728 (8,840,995 )

Net unrealized appreciation/(depreciation) on investments

(2,167,924 ) 10,367,981 (5,046,535 ) 6,868,170

Net gain/(loss) on investments

(2,063,766 ) 1,075,386 (4,413,807 ) (1,972,825 )

NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS

$ (2,193,464 ) $ (6,263,573 ) $ (3,467,142 ) $ (5,082,020 )

23


Table of Contents

Saratoga Investment Corp. CLO 2013-1 Ltd.

Schedule of Investments

November 30, 2014

(unaudited)

Issuer Name

Industry

Asset Name

Asset Type

Current Rate Maturity Date Principal Cost Fair Value

24 Hour Holdings III LLC

Leisure Goods/Activities/Movies Term Loan Loan 3.75 % 5/28/2021 $ 498,750 $ 494,092 $ 492,206

Acosta Holdco Inc.

Media Term Loan B Loan 5.00 % 8/13/2021 2,000,000 1,985,464 2,005,320

Aderant North America, Inc.

Business Equipment and Services Term Loan (First Lien) Loan 5.25 % 12/20/2018 3,260,898 3,260,898 3,228,289

Advantage Sales & Marketing Inc.

Business Equipment and Services Term Loan Loan 4.25 % 7/25/2021 64,516 64,536 63,847

Advantage Sales & Marketing Inc.

Business Equipment and Services Delayed Draw Term Loan Loan 4.25 % 7/25/2021 1,935,484 1,934,254 1,915,432

AECOM Technology Corporation

Business Equipment and Services Term Loan B Loan 3.75 % 10/15/2021 319,903 318,328 320,303

Aegis Toxicology Science Corporation

Healthcare Term B Loan Loan 5.50 % 2/24/2021 997,500 997,500 997,500

Akorn, Inc.

Healthcare Term Loan B Loan 4.50 % 4/16/2021 500,000 497,853 501,250

Albertson’s LLC

Retailers (Except Food and Drugs) Term Loan B-4 Loan 5.50 % 8/25/2021 410,000 407,969 409,827

Albertson’s LLC

Retailers (Except Food and Drugs) Term Loan B-4 Loan 5.50 % 8/25/2021 3,000,000 2,981,665 2,998,740

Alere Inc. (fka IM US Holdings, LLC)

Healthcare Incremental B-1 Term Loan Loan 4.25 % 6/30/2017 1,944,987 1,944,987 1,938,296

American Tire Distributors Inc

Automotive Term Loan Loan 5.75 % 6/1/2018 497,738 497,738 496,806

Anchor Glass

Containers/Glass Products Term Loan Loan 3.25 % 5/16/2021 2,000,000 1,995,153 1,986,500

Applied Systems, Inc.

Business Equipment and Services Initial Term Loan (First Lien) Loan 4.25 % 1/25/2021 496,250 495,146 493,521

Aramark Corporation

Food Products LC-2 Facility Loan 3.69 % 7/26/2016 79,187 79,180 78,494

Aramark Corporation

Food Products LC-3 Facility Loan 3.69 % 7/26/2016 43,961 43,961 43,576

Aramark Corporation

Food Products U.S. Term F Loan Loan 3.25 % 2/24/2021 3,190,505 3,190,505 3,145,965

ARG IH Corp

Food Services Term Loan Loan 4.75 % 11/15/2020 496,250 495,221 496,126

Asurion, LLC (fka Asurion Corporation)

Insurance Incremental Tranche B-1 Term Loan Loan 5.00 % 5/24/2019 5,452,971 5,408,975 5,427,069

Auction.Com, LLC

Business Equipment and Services Term Loan A-4 Loan 4.40 % 2/28/2017 914,567 914,567 905,422

Avantor Performance Materials Holdings, Inc.

Chemicals/Plastics Term Loan Loan 5.25 % 6/26/2017 4,319,115 4,308,260 4,297,520

Avast Software

Electronics/Electric Term Loan Loan 4.00 % 3/20/2020 1,950,000 1,947,791 1,945,125

AZ Chem US Inc.

Chemicals/Plastics Term Loan Loan 5.25 % 12/22/2017 478,767 476,432 476,972

Bass Pro Group, LLC

Retailers (Except Food and Drugs) New Term Loan Loan 3.75 % 11/20/2019 494,899 494,382 491,805

Bayonne Energy Center

Oil & Gas Term Loan B Loan 4.50 % 8/19/2021 982,343 977,524 984,494

Belmond Hotels

Lodging & Casinos Term Loan Loan 4.00 % 3/19/2021 497,500 495,181 492,938

Berry Plastics Corporation

Chemicals/Plastics Term E Loan Loan 3.75 % 1/6/2021 1,814,499 1,801,846 1,786,465

Big Heart Pet Brands (fka Del Monte Corporation)

Food/Drug Retailers Initial Term Loan Loan 3.50 % 3/9/2020 2,985,000 3,004,996 2,880,525

Biomet, Inc.

Healthcare Dollar Term B-2 Loan Loan 3.65 % 7/25/2017 1,840,718 1,840,718 1,836,116

BJ’s Wholesale Club, Inc.

Food/Drug Retailers New 2013 (November) Replacement Loan (First Lien) Loan 4.50 % 9/26/2019 1,493,737 1,492,618 1,482,953

Bombardier Recreational Products Inc.

Leisure Goods/Activities/Movies Term B Loan Loan 4.00 % 1/30/2019 754,286 750,056 746,509

Brickman Group Holdings, Inc.

Brokers/Dealers/Investment Houses Initial Term Loan (First Lien) Loan 4.00 % 12/18/2020 1,494,994 1,482,074 1,477,143

Brock Holdings III, Inc.

Industrial Equipment Term Loan (First Lien) Loan 6.00 % 3/16/2017 1,943,837 1,959,132 1,846,645

Burlington Coat Factory Warehouse Corporation

Retailers (Except Food and Drugs) Term B-2 Loan Loan 4.25 % 2/23/2017 1,995,000 1,985,325 1,985,025

BWAY

Leisure Goods/Activities/Movies Term Loan B Loan 5.50 % 8/14/2020 997,500 987,910 998,747

Caesars Entertainment Corp.

Lodging & Casinos Term B-7 Loan Loan 6.25 % 3/1/2017 997,500 991,102 915,206

Camp International Holding Company

Aerospace and Defense 2013 Replacement Term Loan (First Lien) Loan 4.75 % 5/31/2019 1,965,034 1,970,857 1,969,947

Capital Automotive L.P.

Conglomerate Tranche B-1 Term Loan Facility Loan 4.00 % 4/10/2019 2,084,879 2,089,597 2,079,021

Catalent Pharma Solutions, Inc

Drugs Initial Term B Loan Loan 3.50 % 9/15/2021 498,750 496,327 498,660

Celanese US Holdings LLC

Chemicals/Plastics Dollar Term C-2 Commitment Loan 2.25 % 10/31/2016 2,159,974 2,187,537 2,159,585

Cengage Learning

Publishing Term Loan Loan 7.00 % 3/31/2020 2,738,750 2,769,924 2,737,901

Charter Communications Operating, LLC

Cable and Satellite Television Term F Loan Loan 3.00 % 12/31/2020 2,662,486 2,653,171 2,624,226

CHS/Community Health Systems, Inc.

Healthcare 2017 Term E Loan Loan 3.48 % 1/25/2017 1,100,591 1,074,787 1,098,390

CHS/Community Health Systems, Inc.

Healthcare 2021 Term D Loan Loan 4.25 % 1/27/2021 2,933,441 2,849,143 2,936,492

Cinedigm Digital Funding I, LLC

Business Equipment and Services Term Loan Loan 3.75 % 2/28/2018 633,604 628,590 632,020

CITGO Petroleum

Oil & Gas Term Loan B Loan 4.50 % 7/29/2021 1,000,000 996,338 995,000

ClubCorp Club Operations, Inc.

Lodging & Casinos Term Loan B Loan 4.50 % 7/24/2020 500,000 496,250 498,125

Covanta Energy Corporation

Ecological Services and Equipment Term Loan Loan 3.25 % 3/28/2019 330,833 329,802 329,732

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

Electronics/Electric Term B Loan Loan 4.25 % 4/7/2021 3,604,388 3,604,388 3,562,324

Crosby US Acquisition Corp.

Industrial Equipment Initial Term Loan (First Lien) Loan 4.00 % 11/23/2020 744,375 743,561 716,461

Crown Castle Operating Company

Telecommunications/Cellular Extended Incremental Tranche B-2 Term Loan Loan 3.00 % 1/31/2021 2,441,744 2,439,592 2,431,074

CT Technologies Intermediate Hldgs, Inc

Healthcare Term Loan (First Lien) Loan 6.00 % 11/18/2021 1,500,000 1,485,000 1,492,500

Culligan International Company

Conglomerate Dollar Loan (First Lien) Loan 6.25 % 12/19/2017 783,162 729,780 732,257

Culligan International Company

Conglomerate Dollar Loan (Second Lien) Loan 9.50 % 6/19/2018 781,646 734,775 763,410

Cumulus Media Holdings Inc.

Broadcast Radio and Television Term Loan Loan 4.25 % 12/23/2020 482,438 478,143 474,599

Custom Sensors

Industrial Equipment Term Loan Loan 4.50 % 6/18/2021 500,000 498,799 498,750

DaVita HealthCare Partners Inc. (fka DaVita Inc.)

Healthcare Tranche B Term Loan Loan 4.50 % 10/20/2016 498,750 496,393 495,842

DCS Business Services, Inc.

Financial Intermediaries Term B Loan Loan 7.25 % 3/19/2018 3,468,917 3,443,130 3,418,930

Dealertrack Technologies, Inc.

Leisure Goods/Activities/Movies Term B Loan Loan 3.50 % 2/26/2021 477,011 475,946 471,645

Dell International LLC

Retailers (Except Food and Drugs) Term B Loan Loan 4.50 % 4/29/2020 2,977,481 2,964,580 2,979,595

Delos Finance SARL

Financial Intermediaries Term Loan Loan 3.50 % 3/6/2021 500,000 497,709 498,125

Delta 2 (Lux) S.a.r.l.

Lodging & Casinos Term Loan B-3 Loan 4.75 % 7/30/2021 1,000,000 995,106 986,750

Deluxe Entertainment Service Group, Inc.

Leisure Goods/Activities/Movies Term Loan (First Lien) Loan 6.50 % 2/28/2020 1,981,211 1,982,485 1,812,808

Devix US, Inc.

Chemicals/Plastics Term Loan Loan 4.25 % 4/30/2021 250,000 247,654 247,500

Devix US, Inc.

Chemicals/Plastics Term Loan (Second Lien) Loan 8.00 % 5/2/2022 498,750 496,400 497,089

Diamond Resorts International

Lodging & Casinos Term Loan Loan 5.50 % 5/9/2021 997,500 992,639 999,994

DPX Holdings B.V.

Healthcare Term Loan Loan 4.25 % 3/11/2021 2,992,500 2,985,464 2,920,889

Drew Marine Group Inc.

Chemicals/Plastics Term Loan (First Lien) Loan 4.50 % 11/19/2020 1,493,737 1,499,009 1,476,933

Dunkin’ Brands, Inc.

Food Services Term B-4 Loan Loan 3.25 % 2/7/2021 3,942,384 3,933,806 3,870,593

Education Management LLC

Leisure Goods/Activities/Movies Tranche C-2 Term Loan Loan 4.25 % 6/1/2016 3,905,338 3,818,145 1,732,994

EIG Investors Corp.

Business Equipment and Services Term Loan Loan 5.00 % 11/8/2019 990,000 985,855 990,000

Emerald Performance Materials, LLC

Chemicals/Plastics Term Loan (First Lien) Loan 4.50 % 8/1/2021 500,000 497,576 495,940

Emerald Performance Materials, LLC

Chemicals/Plastics Term Loan (Second Lien) Loan 7.75 % 8/1/2022 500,000 497,511 491,875

EnergySolutions, LLC

Oil & Gas Term Loan B Loan 6.75 % 5/29/2020 997,500 979,024 1,004,981

Enviromental Resources Management

Business Equipment and Services Term Loan Loan 5.00 % 5/16/2021 1,000,000 990,000 995,830

Evergreen Acqco 1 LP

Retailers (Except Food and Drugs) New Term Loan Loan 5.00 % 7/9/2019 977,550 975,180 974,500

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

Industrial Equipment Term Loan (First Lien) Loan 4.75 % 1/15/2021 1,992,500 1,986,969 1,980,047

Federal-Mogul Corporation

Automotive Tranche C Term Loan Loan 4.75 % 4/15/2021 2,992,500 2,978,941 2,983,612

First Data Corporation

Financial Intermediaries 2017 Second New Dollar Term Loan Loan 4.15 % 3/24/2017 2,790,451 2,724,831 2,749,766

First Data Corporation

Financial Intermediaries 2018 Dollar Term Loan Loan 4.15 % 3/23/2018 2,111,028 2,018,373 2,098,362

Fitness International, LLC

Leisure Goods/Activities/Movies Term Loan B Loan 5.50 % 7/1/2020 1,496,250 1,485,504 1,470,694

FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)

Nonferrous Metals/Minerals Loan Loan 3.75 % 6/28/2019 1,987,481 1,987,131 1,848,775

Four Seasons Holdings Inc.

Lodging & Casinos Term Loan (First Lien) Loan 3.50 % 6/29/2020 495,000 495,000 490,877

Garda World Security Corporation

Business Equipment and Services Term B Delayed Draw Loan Loan 4.00 % 11/6/2020 201,667 200,778 198,894

Garda World Security Corporation

Business Equipment and Services Term B Loan Loan 4.00 % 11/6/2020 788,333 784,955 777,494

Gardner Denver, Inc.

Oil & Gas Initial Dollar Term Loan Loan 4.25 % 7/30/2020 2,482,481 2,473,377 2,379,036

Gates Global LLC

Leisure Goods/Activities/Movies Term Loan (First Lien) Loan 4.25 % 7/2/2021 500,000 495,000 494,500

Generac Power Systems, Inc.

Industrial Equipment Term Loan B Loan 3.25 % 5/29/2020 821,138 807,233 799,239

General Nutrition Centers, Inc.

Retailers (Except Food and Drugs) Amended Tranche B Term Loan Loan 3.25 % 3/4/2019 4,728,130 4,712,615 4,606,003

Global Tel*Link Corporation

Business Equipment and Services Term Loan (First Lien) Loan 5.00 % 5/26/2020 2,763,065 2,754,287 2,738,888

Goodyear Tire & Rubber Company, The

Chemicals/Plastics Loan (Second Lien) Loan 4.75 % 4/30/2019 4,000,000 3,953,800 4,011,240

Grosvenor Capital Management Holdings, LP

Brokers/Dealers/Investment Houses Initial Term Loan Loan 3.75 % 1/4/2021 3,473,750 3,457,879 3,404,275

GTCR Valor Companies, Inc.

Business Equipment and Services Term Loan (First Lien) Loan 6.00 % 6/1/2021 2,000,000 1,960,000 1,947,500

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

Publishing Tranche B-4 Term Loan Loan 6.00 % 8/2/2019 490,625 488,469 491,699

HCA Inc.

Healthcare Tranche B-4 Term Loan Loan 2.94 % 5/1/2018 5,677,343 5,404,594 5,652,533

Hertz Corporation, The

Automotive Tranche B-1 Term Loan Loan 3.75 % 3/12/2018 2,947,500 2,985,385 2,909,418

Hoffmaster Group, Inc.

Containers/Glass Products Term Loan Loan 5.25 % 5/8/2020 1,995,000 1,976,131 1,987,519

Hologic, Inc.

Healthcare Refinancing Tranche A Term Loan Loan 2.15 % 8/1/2017 2,187,500 2,183,274 2,168,359

Huntsman International LLC

Chemicals/Plastics Extended Term B Loan Loan 2.69 % 4/19/2017 3,880,270 3,859,264 3,841,468

Husky Injection

Business Equipment and Services Term Loan B Loan 4.25 % 6/30/2021 498,099 495,778 491,125

Ikaria, Inc.

Healthcare Initial Term Loan (First Lien) Loan 5.00 % 2/12/2021 470,660 468,542 471,366

Infor (US), Inc. (fka Lawson Software Inc.)

Business Equipment and Services Tranche B-5 Term Loan Loan 3.75 % 6/30/2020 2,216,721 2,198,833 2,181,896

J. Crew Group, Inc.

Retailers (Except Food and Drugs) Term B-1 Loan Retired 03/05/2014 Loan 4.00 % 3/5/2021 967,638 967,638 917,843

Jazz Acquisition, Inc

Aerospace and Defense First Lien 6/14 Loan 4.50 % 6/19/2021 498,788 497,541 495,985

Kinetic Concepts, Inc.

Healthcare Dollar Term D-1 Loan Loan 4.00 % 5/4/2018 2,483,869 2,457,922 2,470,407

Koosharem, LLC

Business Equipment and Services Term Loan Loan 7.50 % 4/29/2020 997,500 990,756 982,537

La Quinta Holdings, Inc.

Lodging & Casinos Term Loan (First Lien) Loan 4.00 % 4/14/2021 461,938 460,169 459,281

Level 3 Financing, Inc.

Telecommunications Term Loan B Loan 4.50 % 1/31/2022 500,000 496,286 501,095

Mauser Holdings, Inc.

Containers/Glass Products Term Loan Loan 4.50 % 8/2/2021 500,000 497,582 496,875

Michaels Stores, Inc.

Retailers (Except Food and Drugs) Term B Loan Loan 3.75 % 1/28/2020 492,500 492,500 487,851

Michaels Stores, Inc.

Retailers (Except Food and Drugs) Term Loan B-2 Loan 3.75 % 1/28/2020 1,496,250 1,489,059 1,489,307

Microsemi Corporation

Electronics/Electric Incremental Term Loan Loan 3.50 % 2/19/2020 2,393,981 2,389,500 2,365,852

Microsemi Corporation

Electronics/Electric Term Loan Loan 3.75 % 2/19/2020 172,170 172,170 170,591

Midas Intermediate Holdco II, LLC

Automotive Delayed Draw Term Loan Loan 4.75 % 8/18/2021 25,316 25,316 25,356

Midas Intermediate Holdco II, LLC

Automotive Term Loan B Loan 4.75 % 8/18/2021 224,683 223,579 225,034

Millenium Laboratories, LLC

Drugs Term Loan Loan 5.25 % 4/16/2021 1,496,250 1,482,301 1,498,120

Mitel US Holdings, Inc.

Telecommunications Term Loan Loan 5.25 % 1/31/2020 214,164 213,211 214,164

MPH Acquisition Holdings LLC

Health Insurance Term Loan Loan 4.00 % 3/31/2021 463,636 462,528 455,773

MSC Software Corp.

Business Equipment and Services Term Loan Loan 4.00 % 5/29/2020 997,500 988,304 996,253

National CineMedia, LLC

Leisure Goods/Activities/Movies Term Loan (2013) Loan 2.95 % 11/26/2019 1,086,207 1,057,633 1,038,457

National Veterinary Associates, Inc

Healthcare Term Loan B Loan 4.75 % 8/14/2021 1,000,000 995,200 998,750

National Vision, Inc.

Retailers (Except Food and Drugs) Term Loan (Second Lien) Loan 6.75 % 3/11/2022 250,000 249,723 232,500

Newsday, LLC

Publishing Term Loan Loan 3.69 % 10/12/2016 2,215,385 2,214,135 2,198,769

Nortek, Inc.

Electronics/Electric Term B Loan Loan 3.75 % 10/30/2020 997,500 995,116 986,278

Novelis, Inc.

Conglomerate Initial Term Loan Loan 3.75 % 3/10/2017 4,820,028 4,831,154 4,807,978

NPC International, Inc.

Food Services Term Loan (2013) Loan 4.00 % 12/28/2018 487,500 487,500 468,000

NRG Energy, Inc.

Utilities Term Loan (2013) Loan 2.75 % 7/2/2018 3,871,050 3,850,443 3,822,662

NuSil Technology LLC.

Chemicals/Plastics Term Loan Loan 5.25 % 4/7/2017 800,222 800,222 791,971

OEP Pearl Dutch Acquisition B.V.

Chemicals/Plastics Initial BV Term Loan Loan 6.50 % 3/30/2018 136,022 134,681 135,938

Ollie’s Bargain Outlet, Inc

Retailers (Except Food and Drugs) Term Loan Loan 6.00 % 9/30/2019 979,576 975,079 969,781

On Assignment, Inc.

Business Equipment and Services Initial Term B Loan Loan 3.50 % 5/15/2020 1,311,364 1,303,108 1,298,250

Onex Carestream Finance LP

Healthcare Term Loan (First Lien 2013) Loan 5.00 % 6/7/2019 4,226,014 4,209,392 4,226,902

OnexYork Acquisition Co

Healthcare Delayed Draw Term Loan Loan 5.00 % 6/7/2019

OnexYork Acquisition Co

Healthcare Term Loan B Loan 5.00 % 6/7/2019 451,220 447,878 448,719

OpenLink International LLC

Business Equipment and Services Term B Loan Loan 6.25 % 10/27/2017 972,500 972,500 967,638

Orbitz Worldwide, Inc.

Business Equipment and Services Term Loan (First Lien) Loan 4.50 % 4/15/2021 1,498,750 1,496,379 1,492,006

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

Food/Drug Retailers Term Borrowing Loan 4.25 % 6/24/2019 1,451,689 1,444,063 1,409,953

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

Business Equipment and Services Term Loan (First Lien) Loan 5.00 % 10/30/2020 992,500 987,689 977,613

Paragon Offshore Finance

Oil & Gas Term Loan B Loan 3.75 % 7/18/2021 750,000 746,250 638,123

PetCo Animal Supplies Stores, Inc.

Retailers (Except Food and Drugs) New Loans Loan 4.00 % 11/24/2017 1,473,214 1,472,253 1,465,229

PGX Holdings, Inc.

Financial Intermediaries Term Loan Loan 6.25 % 9/9/2020 1,000,000 990,357 993,750

Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)

Conglomerate 2013 Term Loan Loan 4.00 % 12/5/2018 1,945,350 1,921,827 1,939,105

Phillips-Medisize Corporation

Healthcare Term Loan Loan 4.75 % 6/16/2021 498,750 496,414 498,127

Pinnacle Foods Finance LLC

Food Products New Term Loan G Loan 3.25 % 4/29/2020 2,581,332 2,576,266 2,541,399

Planet Fitness Holdings LLC

Leisure Goods/Activities/Movies Term Loan Loan 4.75 % 3/31/2021 1,492,500 1,485,577 1,485,038

Polymer Group, Inc.

Chemicals/Plastics Initial Loan Loan 5.25 % 12/19/2019 496,250 493,975 496,870

Prestige Brands, Inc.

Drugs Term B-1 Loan Loan 3.75 % 1/31/2019 390,152 385,864 390,152

Prestige Brands, Inc.

Leisure Goods/Activities/Movies Term Loan Loan 4.50 % 9/3/2021 1,972,222 1,968,727 1,982,083

Progressive Waste Solutions Ltd.

Ecological Services and Equipment Term B Loan Loan 3.00 % 10/24/2019 494,962 494,962 496,407

QoL Meds, LLC

Healthcare Term Loan B Loan 5.50 % 7/15/2020 2,000,000 1,990,530 1,990,000

Quintiles Transnational Corp.

Conglomerate Term B-3 Loan Loan 3.75 % 6/8/2018 3,672,340 3,642,784 3,652,840

Ranpak Holdings, Inc.

Business Equipment and Services Term Loan Loan 4.75 % 10/1/2021 1,000,000 997,539 996,250

Ranpak Holdings, Inc.

Business Equipment and Services Term Loan (Second Lien) Loan 8.25 % 9/30/2022 500,000 497,617 499,585

Redtop Acquisitions Limited

Electronics/Electric Initial Dollar Term Loan (First Lien) Loan 4.50 % 12/3/2020 496,250 493,090 495,009

Rexnord LLC/RBS Global, Inc.

Industrial Equipment Term B Loan Loan 4.00 % 8/21/2020 1,650,968 1,652,341 1,637,893

Reynolds Group Holdings Inc.

Industrial Equipment Incremental U.S. Term Loan Loan 4.00 % 12/1/2018 1,965,150 1,965,150 1,955,501

Rocket Software, Inc.

Business Equipment and Services Term Loan (First Lien) Loan 5.75 % 2/8/2018 1,916,674 1,897,240 1,916,674

Rovi Solutions Corporation / Rovi Guides, Inc.

Electronics/Electric Tranche B-3 Term Loan Loan 3.50 % 3/29/2019 1,496,250 1,489,116 1,471,472

RPI Finance Trust

Drugs Term B-2 Term Loan Loan 3.25 % 5/9/2018 5,220,614 5,199,989 5,198,844

SBP Holdings LP

Industrial Equipment Term Loan (First Lien) Loan 5.00 % 3/27/2021 995,000 990,400 965,150

Scientific Games International, Inc.

Electronics/Electric Term Loan B2 Loan 6.00 % 10/1/2021 1,000,000 990,176 983,630

Scitor Corporation

Business Equipment and Services Term Loan Loan 5.00 % 2/15/2017 463,977 462,198 458,758

Seadrill

Oil & Gas Term Loan B Loan 4.00 % 2/21/2021 1,000,000 917,500 870,710

Sensata Technologies B.V./Sensata Technology Finance Company, LLC

Industrial Equipment Term Loan Loan 3.25 % 5/13/2019 1,513,266 1,513,266 1,513,266

Sensus USA Inc. (fka Sensus Metering Systems)

Utilities Term Loan (First Lien) Loan 4.75 % 5/9/2017 1,930,054 1,925,009 1,886,628

ServiceMaster Company, The

Conglomerate Tranche B Term Loan Loan 4.40 % 1/31/2017 2,000,000 1,980,986 1,984,500

Shearers Foods LLC

Food Services Term Loan (First Lien) Loan 4.50 % 6/30/2021 1,000,000 997,512 996,880

Sonneborn, LLC

Chemicals/Plastics Initial US Term Loan Loan 5.50 % 12/10/2020 770,792 759,038 770,314

Sophia, L.P.

Electronics/Electric Term B Loan Loan 4.00 % 7/19/2018 888,561 879,534 882,786

SourceHOV LLC

Business Equipment and Services Term Loan B (First Lien) Loan 7.75 % 10/31/2019 2,000,000 1,940,000 1,939,160

Southwire Company, LLC (f.k.a Southwire Company)

Building and Development Initial Term Loan Loan 3.25 % 2/10/2021 497,500 496,388 483,998

SRAM, LLC

Industrial Equipment Term Loan (First Lien) Loan 5.25 % 4/10/2020 3,029,045 3,018,608 2,964,678

SS&C Technologies Holdings Europe S.A.R.L.

Business Equipment and Services 2013 Replacement Term B-2 Loan Loan 3.25 % 6/7/2019 50,646 50,211 50,773

SS&C Technologies, Inc., /Sunshine Acquisition II, Inc.

Business Equipment and Services 2013 Replacement Term B-1 Loan Loan 3.25 % 6/7/2019 489,581 485,413 490,804

Steak ‘n Shake Operations, Inc.

Food Services Term Loan Loan 4.75 % 3/19/2021 995,000 985,894 990,025

STHI Holding

Healthcare Term Loan Loan 4.50 % 8/6/2021 1,000,000 1,000,000 996,670

SunGard Data Systems Inc. (Solar Capital Corp.)

Conglomerate Tranche C Term Loan Loan 3.90 % 2/28/2017 285,352 282,854 284,639

SunGard Data Systems Inc. (Solar Capital Corp.)

Conglomerate Tranche E Term Loan Loan 4.00 % 3/9/2020 3,707,953 3,614,501 3,694,975

SuperMedia Inc. (fka Idearc Inc.)

Publishing Loan Loan 11.60 % 12/30/2016 246,572 239,414 199,518

Syniverse Holdings, Inc.

Telecommunications Initial Term Loan Loan 4.00 % 4/23/2019 479,913 475,914 470,915

Taminco Global Chemical Corporation

Chemicals/Plastics Initial Tranche B-3 Dollar Term Loan Loan 3.25 % 2/15/2019 1,462,809 1,454,095 1,455,948

TGI Friday’s

Food Services Term Loan B Loan 5.25 % 7/15/2020 981,136 976,588 979,910

TPF II Power LLC and TPF II Covert Midco LLC

Utilities Term Loan B Loan 5.50 % 10/2/2021 500,000 496,450 502,345

TransDigm, Inc.

Aerospace and Defense Tranche C Term Loan Loan 3.75 % 2/28/2020 4,859,419 4,869,067 4,814,858

TransFirst

Financial Intermediaries Term Loan Loan 5.50 % 11/12/2021 500,000 495,011 501,095

TransUnion

Financial Intermediaries Term Loan Loan 4.00 % 4/9/2021 497,500 496,320 492,649

Tricorbraun, Inc. (fka Kranson Industries, Inc.)

Containers/Glass Products Term Loan Loan 4.00 % 5/3/2018 1,902,083 1,894,387 1,882,264

Truven Health Analytics Inc. (fka Thomson Reuters (Healthcare) Inc.)

Healthcare New Tranche B Term Loan Loan 4.50 % 6/6/2019 488,806 480,655 478,214

Twin River Management Group, Inc.

Lodging & Casinos Term Loan B Loan 5.25 % 7/10/2020 997,500 999,865 1,003,734

U.S. Security Associates Holdings, Inc.

Business Equipment and Services Delayed Draw Loan Loan 6.00 % 7/28/2017 158,925 157,926 157,932

U.S. Security Associates Holdings, Inc.

Business Equipment and Services Term B Loan Loan 6.00 % 7/28/2017 933,452 928,045 927,618

United Surgical Partners International, Inc.

Healthcare New Tranche B Term Loan Loan 4.75 % 4/3/2019 2,437,937 2,413,454 2,436,425

Univar Inc.

Chemicals/Plastics Term B Loan Loan 5.00 % 6/30/2017 3,854,959 3,854,719 3,810,781

Univision Communications Inc.

Telecommunications Replacement First-Lien Term Loan Loan 4.00 % 3/1/2020 2,955,169 2,938,967 2,924,701

Valeant Pharmaceuticals International, Inc.

Drugs Series D2 Term Loan B Loan 3.75 % 2/13/2019 2,545,588 2,537,039 2,528,813

Verint Systems Inc.

Business Equipment and Services Term Loan Loan 3.50 % 9/6/2019 1,264,058 1,259,400 1,261,530

Vertafore, Inc.

Business Equipment and Services Term Loan (2013) Loan 4.25 % 10/3/2019 2,881,003 2,881,003 2,869,594

Vouvray US Finance

Industrial Equipment Term Loan Loan 5.00 % 6/28/2021 498,750 496,358 495,947

Washington Inventory Service

Business Equipment and Services U.S. Term Loan (First Lien) Loan 6.75 % 12/20/2018 1,832,876 1,853,317 1,803,092

Wendy’s International, Inc

Food Services Term B Loan Loan 3.25 % 5/15/2019 675,340 669,494 670,768

West Corporation

Telecommunications Term B-10 Loan Loan 3.25 % 6/30/2018 2,571,560 2,608,260 2,540,212

$ 300,731,616 $ 297,038,596

24


Table of Contents

Saratoga Investment Corp. CLO 2013-1 Ltd.

Schedule of Investments

February 28, 2014

Issuer Name

Industry

Asset Name

Asset Type

Current Rate Maturity Date Principal Cost Fair Value

Academy, LTD.

Retailers (Except Food and Drugs) Initial Term Loan (2012) Loan 4.50 % 8/3/2018 $ 1,960,187 $ 1,948,853 $ 1,969,969

Acosta, Inc.

Food Products Term B Loan (2013) Loan 4.25 % 3/2/2018 4,162,740 4,101,035 4,177,310

Aderant North America, Inc.

Business Equipment and Services Term Loan (First Lien) Loan 6.25 % 12/20/2018 3,473,750 3,470,186 3,482,434

Aegis Toxicology Sciences Corporation

Healthcare Initial Term Loan (First Lien) Loan 5.50 % 2/24/2021 1,000,000 990,000 990,000

Aegis Toxicology Sciences Corporation

Healthcare Initial Term Loan (Second Lien) Loan 9.50 % 8/24/2021 500,000 492,500 492,500

Aeroflex Incorporated

Aerospace and Defense Tranche B-1 Term Loan Loan 4.50 % 11/9/2019 3,208,854 3,194,690 3,223,550

Akorn, Inc.

Healthcare Term Loan B Loan 4.50 % 11/13/2020 500,000 497,500 503,125

Alere Inc. (fka IM US Holdings, LLC)

Healthcare Incremental B-1 Term Loan Loan 4.25 % 6/30/2017 1,960,000 1,930,566 1,968,173

Applied Systems, Inc.

Business Equipment and Services Term Loan Loan 4.25 % 12/8/2016 500,000 498,750 498,750

Aramark Corporation

Food Products LC-2 Facility Loan 3.69 % 7/26/2016 79,187 79,187 79,206

Aramark Corporation

Food Products LC-3 Facility Loan 3.69 % 7/26/2016 43,961 43,961 43,971

Aramark Corporation

Food Products U.S. Term C Loan Loan 3.25 % 7/26/2016 3,206,537 3,206,537 3,207,307

Ardagh Holdings USA Inc. (Ardagh Packaging Finance S.A.)

Containers/Glass Products Dollar Term Loan Loan 4.25 % 12/17/2019 1,000,000 995,109 1,002,500

ARG IH Corporation

Food Services Term Loan Loan 5.00 % 11/15/2020 500,000 498,797 502,500

Asurion, LLC (fka Asurion Corporation)

Insurance Incremental Tranche B-1 Term Loan Loan 4.50 % 5/24/2019 5,508,783 5,462,695 5,516,660

Auction.Com, LLC

Business Equipment and Services Term Loan A-4 Loan 4.66 % 2/28/2017 980,651 979,812 970,845

Autotrader.com, Inc.

Automotive Tranche B-1 Term Loan Loan 4.00 % 12/15/2016 3,791,778 3,791,778 3,805,997

Avantor Performance Materials Holdings, Inc.

Chemicals/Plastics Term Loan Loan 5.25 % 6/24/2017 4,875,000 4,861,403 4,875,000

AZ Chem US Inc.

Chemicals/Plastics Term Loan Loan 5.25 % 12/22/2017 1,355,941 1,329,859 1,362,720

Bass Pro Group, LLC

Retailers (Except Food and Drugs) New Term Loan Loan 3.75 % 11/20/2019 498,725 498,126 500,715

Berry Plastics Corporation

Chemicals/Plastics Term E Loan Loan 3.75 % 1/6/2021 1,500,000 1,496,250 1,495,500

Big Heart Pet Brands (fka Del Monte Corporation)

Food/Drug Retailers Initial Term Loan Loan 3.50 % 3/9/2020 3,000,000 3,022,866 2,999,250

Biomet, Inc.

Healthcare Dollar Term B-2 Loan Loan 3.65 % 7/25/2017 1,970,137 1,970,137 1,972,797

BJ’s Wholesale Club, Inc.

Food/Drug Retailers New 2013 (November) Replacement Loan (First Lien) Loan 4.50 % 9/26/2019 500,000 497,592 502,750

Bombardier Recreational Products Inc.

Leisure Goods/Activities/Movies Term B Loan Loan 4.00 % 1/30/2019 754,286 748,080 756,647

Brickman Group Ltd. LLC, The

Brokers/Dealers/Investment Houses Initial Term Loan (First Lien) Loan 4.00 % 12/18/2020 250,000 248,750 250,937

Brock Holdings III, Inc.

Industrial Equipment Term Loan (First Lien) Loan 6.75 % 3/16/2017 1,959,839 1,976,826 1,967,188

Burlington Coat Factory Warehouse Corporation

Retailers (Except Food and Drugs) Term B-2 Loan Loan 4.25 % 2/23/2017 2,660,377 2,653,889 2,675,675

C.H.I. Overhead Doors, Inc.

Building and Development Term Loan (First Lien) Loan 5.50 % 3/18/2019 2,739,013 2,692,934 2,745,861

Camp International Holding Company

Aerospace and Defense 2013 Replacement Term Loan (First Lien) Loan 4.75 % 5/31/2019 990,000 990,000 999,900

Capital Automotive L.P.

Conglomerate Tranche B-1 Term Loan Facility Loan 4.00 % 4/10/2019 2,137,369 2,141,920 2,142,712

Capstone Logistics, LLC

Business Equipment and Services Term Note A Loan 6.50 % 9/16/2016 2,658,626 2,637,550 2,618,899

Capsugel Holdings US, Inc.

Drugs Initial Term Loan Loan 3.50 % 8/1/2018 3,145,521 3,138,959 3,141,589

Celanese US Holdings LLC

Chemicals/Plastics Dollar Term C-2 Commitment Loan 2.25 % 10/31/2016 2,176,323 2,201,894 2,192,254

Charter Communications Operating, LLC

Cable and Satellite Television Term F Loan Loan 3.00 % 12/31/2020 2,682,707 2,672,727 2,666,369

CHS/Community Health Systems, Inc.

Healthcare 2017 Term E Loan Loan 3.48 % 1/25/2017 1,108,908 1,082,718 1,113,987

CHS/Community Health Systems, Inc.

Healthcare 2021 Term D Loan Loan 4.25 % 1/27/2017 2,955,608 2,862,024 2,980,228

Cinedigm Digital Funding I, LLC

Business Equipment and Services Term Loan Loan 3.75 % 2/28/2018 825,121 820,892 825,121

Covanta Energy Corporation

Ecological Services and Equipment Term Loan Loan 3.50 % 3/28/2019 491,250 489,468 492,788

CPI International Acquisition, Inc. (f/k/a Catalyst Holdings, Inc.)

Electronics/Electric Term B Loan Loan 5.00 % 2/13/2017 4,622,500 4,611,092 4,622,500

Crosby US Acquisition Corp.

Industrial Equipment Initial Term Loan (First Lien) Loan 4.00 % 11/23/2020 750,000 749,094 748,312

Crown Castle Operating Company

Telecommunications/Cellular Extended Incremental Tranche B-2 Term Loan Loan 3.25 % 1/31/2019 2,460,196 2,441,025 2,460,316

Culligan International Company

Conglomerate Dollar Loan (First Lien) Loan 6.25 % 12/19/2017 787,658 738,102 734,491

Culligan International Company

Conglomerate Dollar Loan (Second Lien) Loan 9.50 % 6/19/2018 783,162 732,061 657,856

Cumulus Media Holdings Inc.

Broadcast Radio and Television Term Loan Loan 4.25 % 12/23/2020 500,000 495,000 502,815

DaVita HealthCare Partners Inc. (fka DaVita Inc.)

Healthcare Tranche B Term Loan Loan 4.50 % 10/20/2016 3,909,320 3,909,320 3,927,655

DCS Business Services, Inc.

Financial Intermediaries Term B Loan Loan 7.25 % 3/19/2018 3,831,595 3,792,824 3,735,805

DealerTrack Technologies, Inc.

Computers & Electronics Term Loan Loan 3.50 % 2/28/2021 500,000 498,750 498,750

Dell International LLC

Retailers (Except Food and Drugs) Term B Loan Loan 4.50 % 4/29/2020 1,995,000 1,982,818 1,988,935

Delos Finance

Leasing Loan Loan 3.50 % 2/26/2021 500,000 497,500 497,500

Deluxe Entertainment Services Group Inc.

Media Initial Term Loan Loan 6.50 % 2/28/2020 1,000,000 1,000,000 1,000,000

Digitalglobe, Inc.

Ecological Services and Equipment Term Loan Loan 3.75 % 1/31/2020 248,125 248,125 247,815

Drew Marine Group Inc.

Chemicals/Plastics Term Loan (First Lien) Loan 4.50 % 11/19/2020 500,000 499,397 502,500

Dunkin’ Brands, Inc.

Food Services Term B-4 Loan Loan 3.25 % 2/14/2020 3,956,731 3,946,925 3,936,948

DynCorp International Inc.

Aerospace and Defense Term Loan Loan 6.25 % 7/7/2016 486,442 482,619 488,573

Education Management LLC

Leisure Goods/Activities/Movies Tranche C-2 Term Loan Loan 4.31 % 6/1/2016 3,882,152 3,746,734 3,544,405

EIG Investors Corp.

Business Equipment and Services Term Loan Loan 5.00 % 11/9/2019 997,500 992,713 1,003,734

Energy Transfer Equity, L.P.

Oil & Gas Loan Loan 3.25 % 12/2/2019 1,000,000 997,599 998,750

Evergreen Acqco 1 LP

Retailers (Except Food and Drugs) New Term Loan Loan 5.00 % 7/9/2019 492,516 488,615 493,900

EWT Holdings III Corp. (fka WTG Holdings III Corp.)

Industrial Equipment Term Loan (First Lien) Loan 4.75 % 1/15/2021 1,000,000 995,084 1,002,500

Federal-Mogul Corporation

Automotive Tranche B Term Loan Loan 2.14 % 12/29/2014 2,220,981 2,187,068 2,202,747

Federal-Mogul Corporation

Automotive Tranche C Term Loan Loan 2.14 % 12/28/2015 1,307,032 1,270,847 1,296,301

First Data Corporation

Financial Intermediaries 2017 Second New Dollar Term Loan Loan 4.20 % 3/24/2017 2,111,028 2,010,799 2,109,276

First Data Corporation

Financial Intermediaries 2018 Dollar Term Loan Loan 4.20 % 3/23/2018 2,290,451 2,231,370 2,292,741

FMG Resources (August 2006) Pty LTD (FMG America Finance, Inc.)

Nonferrous Metals/Minerals Loan Loan 4.25 % 6/28/2019 997,500 995,122 1,006,438

Four Seasons Holdings Inc.

Lodging & Casinos Term Loan (First Lien) Loan 3.50 % 6/27/2020 498,750 498,750 498,750

Garda World Security Corporation

Business Equipment and Services Term B Delayed Draw Loan Loan 4.00 % 11/6/2020 203,194 202,218 203,363

Garda World Security Corporation

Business Equipment and Services Term B Loan Loan 4.00 % 11/6/2020 794,306 790,489 794,965

Gardner Denver, Inc.

Oil & Gas Initial Dollar Term Loan Loan 4.25 % 7/30/2020 1,496,250 1,485,394 1,489,337

Generac Power Systems, Inc.

Industrial Equipment Term Loan B Loan 3.50 % 5/31/2020 868,414 852,908 868,258

General Nutrition Centers, Inc.

Retailers (Except Food and Drugs) Amended Tranche B Term Loan Loan 3.25 % 3/4/2019 4,740,112 4,722,664 4,725,892

Global Tel*Link Corporation

Business Equipment and Services Term Loan (First Lien) Loan 5.00 % 5/23/2020 1,920,175 1,915,905 1,900,014

Goodyear Tire & Rubber Company, The

Chemicals/Plastics Loan (Second Lien) Loan 4.75 % 4/30/2019 4,000,000 3,941,039 4,037,000

Grosvenor Capital Management Holdings, LP

Brokers/Dealers/Investment Houses Initial Term Loan Loan 3.75 % 1/4/2021 3,500,000 3,482,803 3,489,080

Harland Clarke Holdings Corp. (fka Clarke American Corp.)

Publishing Tranche B-4 Term Loan Loan 6.00 % 8/4/2019 500,000 497,500 500,780

HCA Inc.

Healthcare Tranche B-4 Term Loan Loan 2.94 % 5/1/2018 5,720,353 5,390,148 5,713,947

Hertz Corporation, The

Automotive Tranche B-1 Term Loan Loan 3.75 % 3/11/2018 2,970,000 3,005,791 2,973,683

Hologic, Inc.

Healthcare Refinancing Tranche A Term Loan Loan 2.19 % 8/1/2017 2,312,500 2,307,973 2,313,425

Hunter Defense Technologies, Inc.

Aerospace and Defense Term Loan Loan 3.45 % 8/22/2014 3,470,285 3,460,723 3,262,068

Huntsman International LLC

Chemicals/Plastics Extended Term B Loan Loan 2.73 % 4/19/2017 3,920,000 3,892,467 3,919,020

Ikaria, Inc.

Healthcare Initial Term Loan (First Lien) Loan 5.00 % 2/12/2021 500,000 497,515 502,815

Infor (US), Inc. (fka Lawson Software Inc.)

Business Equipment and Services Tranche B-5 Term Loan Loan 3.75 % 6/3/2020 1,776,183 1,758,861 1,772,488

Inventiv Health, Inc. (fka Ventive Health, Inc)

Conglomerate Consolidated Term Loan Loan 7.50 % 8/4/2016 492,090 492,090 491,105

J. Crew Group, Inc.

Retailers (Except Food and Drugs) Term B-1 Loan Retired 03/05/2014 Loan 4.00 % 3/7/2018 972,500 972,500 972,656

JFB Firth Rixson Inc.

Industrial Equipment 2013 Replacement Dollar Term Facility Loan Loan 4.25 % 6/30/2017 2,564,311 2,554,534 2,568,054

Kinetic Concepts, Inc.

Healthcare Dollar Term D-1 Loan Loan 4.00 % 5/4/2018 490,057 475,404 492,508

La Quinta Intermediate Holdings L.L.C

Gaming and Hotels Initial Term Loan Loan 4.00 % 2/19/2021 500,000 500,000 500,000

Michaels Stores, Inc.

Retailers (Except Food and Drugs) Term B Loan Loan 3.75 % 1/28/2020 496,250 496,250 497,302

Microsemi Corporation

Electronics/Electric Incremental Term Loan Loan 3.75 % 2/19/2020 498,750 498,750 499,373

Microsemi Corporation

Electronics/Electric Term Loan Loan 3.50 % 2/19/2020 2,393,981 2,389,463 2,398,482

Mitel US Holdings, Inc.

Telecommunications Term Loan Loan 5.25 % 1/31/2020 250,000 248,753 252,083

National CineMedia, LLC

Leisure Goods/Activities/Movies Term Loan (2013) Loan 2.95 % 11/26/2019 1,086,207 1,054,177 1,082,134

Newsday, LLC

Publishing Term Loan Loan 3.69 % 10/12/2016 2,215,385 2,213,416 2,215,385

Novelis, Inc.

Conglomerate Initial Term Loan Loan 3.75 % 3/10/2017 4,857,520 4,868,347 4,873,452

NPC International, Inc.

Food Services Term Loan (2013) Loan 4.00 % 12/28/2018 490,833 490,833 493,597

NRG Energy, Inc.

Utilities Term Loan (2013) Loan 2.75 % 7/1/2018 3,900,525 3,875,534 3,872,168

NuSil Technology LLC.

Chemicals/Plastics Term Loan Loan 5.25 % 4/7/2017 809,163 809,163 799,558

OEP Pearl Dutch Acquisition B.V.

Chemicals/Plastics Initial BV Term Loan Loan 6.50 % 3/30/2018 142,422 140,466 143,846

On Assignment, Inc.

Business Equipment and Services Initial Term B Loan Loan 3.50 % 5/15/2020 1,311,364 1,303,125 1,312,190

Onex Carestream Finance LP

Healthcare Term Loan (First Lien 2013) Loan 5.00 % 2/25/2017 4,531,159 4,511,264 4,582,135

OpenLink International, Inc.

Computers & Electronics Replacement Term Loan Loan 6.25 % 10/30/2017 980,000 980,000 980,000

P.F. Chang’s China Bistro, Inc. (Wok Acquisition Corp.)

Food/Drug Retailers Term Borrowing Loan 5.50 % 6/22/2019 1,496,212 1,488,641 1,509,675

P2 Upstream Acquisition Co. (P2 Upstream Canada BC ULC)

Business Equipment and Services Term Loan (First Lien) Loan 5.00 % 10/30/2020 1,000,000 995,186 1,008,750

Patheon Inc.

Healthcare Term Loan Loan 4.25 % 3/11/2021 3,000,000 2,992,500 2,990,640

PetCo Animal Supplies, Inc.

Retailers (Except Food and Drugs) New Loans Loan 4.00 % 11/24/2017 1,484,694 1,483,250 1,489,103

Pharmaceutical Product Development, Inc. (Jaguar Holdings, LLC)

Conglomerate 2013 Term Loan Loan 4.00 % 12/5/2018 1,960,200 1,936,226 1,967,845

Pinnacle Foods Finance LLC

Food Products New Term Loan G Loan 3.25 % 4/29/2020 4,962,500 4,951,514 4,942,352

Polymer Group, Inc.

Chemicals/Plastics Initial Loan Loan 5.25 % 12/19/2019 500,000 497,500 501,875

Prestige Brands, Inc.

Drugs Term B-1 Loan Loan 3.75 % 1/31/2019 435,606 430,195 437,022

Pro Mach, Inc.

Industrial Equipment Term Loan Loan 4.50 % 7/6/2017 1,945,655 1,934,699 1,955,383

Progressive Waste Solutions Ltd.

Ecological Services and Equipment Term B Loan Loan 3.00 % 10/24/2019 498,741 498,741 500,486

Quintiles Transnational Corp.

Conglomerate Term B-3 Loan Loan 3.75 % 6/8/2018 3,681,541 3,646,328 3,685,186

Redtop Acquisitions Limited

Electronics/Electric Initial Dollar Term Loan (First Lien) Loan 4.50 % 12/3/2020 500,000 496,369 502,915

Rexnord LLC/RBS Global, Inc.

Industrial Equipment Term B Loan Loan 4.00 % 4/1/2018 1,663,476 1,663,476 1,667,035

Reynolds Group Holdings Inc.

Industrial Equipment Incremental U.S. Term Loan Loan 4.00 % 9/28/2018 1,980,000 1,980,000 1,993,365

Rocket Software, Inc.

Business Equipment and Services Term Loan (First Lien) Loan 5.75 % 2/8/2018 1,960,025 1,934,083 1,960,515

Rovi Solutions Corporation / Rovi Guides, Inc.

Electronics/Electric Tranche A-2 Loan Loan 2.45 % 3/29/2017 1,562,552 1,552,098 1,562,552

Rovi Solutions Corporation / Rovi Guides, Inc.

Electronics/Electric Tranche B-3 Term Loan Loan 3.50 % 3/29/2019 1,344,450 1,339,560 1,341,088

RPI Finance Trust

Drugs Term B-2 Term Loan Loan 3.25 % 5/9/2018 5,308,218 5,283,397 5,339,165

Scitor Corporation

Business Equipment and Services Term Loan Loan 5.00 % 2/15/2017 463,977 462,831 460,354

Sensata Technologies B.V./Sensata Technology Finance Company, LLC

Industrial Equipment Term Loan Loan 3.25 % 5/12/2019 1,524,730 1,524,730 1,529,106

Sensus USA Inc. (fka Sensus Metering Systems)

Utilities Term Loan (First Lien) Loan 5.75 % 5/9/2017 1,945,013 1,939,821 1,957,987

ServiceMaster Company, The

Conglomerate Tranche B Term Loan Loan 4.45 % 1/31/2017 2,822,729 2,830,165 2,825,552

SI Organization, Inc., The

Aerospace and Defense New Tranche B Term Loan Loan 5.50 % 11/22/2016 3,880,675 3,863,008 3,800,655

Sonneborn, LLC

Chemicals/Plastics Initial US Term Loan Loan 6.50 % 3/30/2018 807,059 795,976 815,130

Sophia, L.P.

Electronics/Electric Term B Loan Loan 4.50 % 7/19/2018 928,389 917,174 934,191

Southwire Company, LLC (f.k.a Southwire Company)

Building and Development Initial Term Loan Loan 3.25 % 2/10/2021 500,000 498,758 499,730

SRA International Inc.

Aerospace and Defense Term Loan Loan 6.50 % 7/20/2018 3,268,571 3,184,532 3,276,743

SRAM, LLC

Industrial Equipment Term Loan (First Lien) Loan 4.01 % 4/10/2020 3,304,614 3,278,551 3,304,614

SS&C Technologies Holdings Europe S.A.R.L.

Business Equipment and Services 2013 Replacement Term B-2 Loan Loan 3.25 % 6/7/2019 64,638 64,070 64,839

SS&C Technologies, Inc., /Sunshine Acquisition II, Inc.

Business Equipment and Services 2013 Replacement Term B-1 Loan Loan 3.25 % 6/7/2019 624,838 619,344 626,782

SunCoke Energy, Inc.

Nonferrous Metals/Minerals Tranche B Term Loan Loan 4.00 % 7/26/2018 1,367,311 1,359,200 1,367,311

SunGard Data Systems Inc (Solar Capital Corp.)

Conglomerate Tranche C Term Loan Loan 3.95 % 2/28/2017 304,311 302,167 305,452

SunGard Data Systems Inc (Solar Capital Corp.)

Conglomerate Tranche E Term Loan Loan 4.00 % 3/8/2020 4,221,845 4,096,936 4,238,944

SuperMedia Inc. (fka Idearc Inc.)

Publishing Loan Loan 11.60 % 12/30/2016 264,330 257,131 196,762

Syniverse Holdings, Inc.

Telecommunications Initial Term Loan Loan 4.00 % 4/23/2019 479,913 476,371 480,911

Taminco Global Chemical Corporation

Chemicals/Plastics Initial Tranche B-3 Dollar Term Loan Loan 3.25 % 2/15/2019 1,473,863 1,464,165 1,473,406

Team Health, Inc.

Healthcare Tranche B Term Loan Loan 3.75 % 6/29/2018 4,387,500 4,373,856 4,387,500

TECTUM HOLDINGS INC

Industrial Equipment Term Loan Loan 6.50 % 12/3/2015 3,800,160 3,788,706 3,762,159

Tomkins, LLC / Tomkins, Inc. (f/k/a Pinafore, LLC / Pinafore, Inc.)

Conglomerate Term B-2 Loan Loan 3.75 % 9/29/2016 2,356,680 2,360,795 2,361,982

TransDigm Inc.

Aerospace and Defense Tranche C Term Loan Loan 3.75 % 2/28/2020 4,896,514 4,904,843 4,914,876

Tricorbraun Inc. (fka Kranson Industries, Inc.)

Containers/Glass Products Term Loan Loan 4.00 % 5/3/2018 1,902,083 1,895,432 1,903,282

Truven Health Analytics Inc. (fka Thomson Reuters (Healthcare) Inc.)

Healthcare New Tranche B Term Loan Loan 4.50 % 6/6/2019 492,528 484,755 493,513

U.S. Security Associates Holdings, Inc.

Business Equipment and Services Delayed Draw Loan Loan 6.00 % 7/28/2017 160,148 159,235 160,348

U.S. Security Associates Holdings, Inc.

Business Equipment and Services Term B Loan Loan 6.00 % 7/28/2017 122,494 122,109 122,648

U.S. Security Associates Holdings, Inc.

Business Equipment and Services Term B Loan Loan 6.00 % 7/28/2017 818,172 813,513 819,195

U.S. Silica Company

Nonferrous Metals/Minerals Term Loan Loan 4.00 % 7/23/2020 1,950,200 1,941,292 1,954,256

U.S. Xpress Enterprises, Inc.

Industrial Equipment Extended Term Loan Loan 9.38 % 11/13/2016 2,805,278 2,766,405 2,777,225

United Surgical Partners International, Inc.

Healthcare New Tranche B Term Loan Loan 4.75 % 4/3/2019 2,456,500 2,429,626 2,470,821

Univar Inc.

Chemicals/Plastics Term B Loan Loan 5.00 % 6/30/2017 3,884,944 3,884,238 3,859,225

Univision Communications Inc.

Telecommunications Replacement First-Lien Term Loan Loan 4.00 % 3/1/2020 2,977,500 2,959,200 2,984,467

UPC Financing Partnership

Broadcast Radio and Television Facility AF Loan 4.00 % 1/31/2021 1,000,000 974,618 1,002,500

Valeant Pharmaceuticals International, Inc.

Drugs Series D2 Term Loan B Loan 3.75 % 2/13/2019 2,947,688 2,936,432 2,955,528

Verint Systems Inc.

Business Equipment and Services Term Loan Loan 4.00 % 9/6/2019 1,900,800 1,892,737 1,904,602

Verint Systems Inc.

Business Equipment and Services Tranche B Incremental Term Loan Loan 3.50 % 9/6/2019 1,000,000 997,521 1,000,000

Vertafore, Inc.

Business Equipment and Services Term Loan (2013) Loan 4.25 % 10/3/2019 2,899,621 2,899,621 2,909,770

Visant Corporation (fka Jostens)

Leisure Goods/Activities/Movies Tranche B Term Loan (2011) Loan 5.25 % 12/22/2016 3,658,446 3,658,446 3,607,008

W.R. Grace & Co.-CONN

Chemicals/Plastics Delayed Draw Term Loan Loan 0.00 % 2/3/2021 (328 )

W.R. Grace & Co.-CONN

Chemicals/Plastics U.S. Term Loan Loan 3.00 % 2/3/2021 368,421 367,502 367,828

Washington Inventory Service

Business Equipment and Services U.S. Term Loan (First Lien) Loan 6.75 % 12/20/2018 1,980,000 2,004,187 1,965,150

Wendy’s International, Inc

Food Services Term B Loan Loan 3.25 % 5/15/2019 680,469 674,563 679,197

Wesco Aircraft Hardware Corp.

Aerospace and Defense Tranche B Term Loan Loan 4.75 % 2/28/2021 500,000 498,750 498,750

West Corporation

Telecommunications Term B-10 Loan Loan 3.25 % 6/30/2018 2,926,111 2,976,179 2,909,666

$ 299,137,566 $ 300,491,077

25


Table of Contents

Note 5. Agreements and Related Party Transactions

On July 30, 2010, the Company entered into the Management Agreement with our Manager. The initial term of the Management Agreement is two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. On July 10, 2014, our board of directors approved the renewal of the Management Agreement for an additional one-year term. Pursuant to the Management Agreement, our Manager implements our business strategy on a day-to-day basis and performs certain services for us, subject to oversight by our board of directors. Our Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investments transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, we have agreed to pay our Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive fee.

The base management fee of 1.75% is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters, and appropriately adjusted for any share issuances or repurchases during the applicable fiscal quarter.

The incentive fee consists of the following two parts:

The first, payable quarterly in arrears, equals 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875% quarterly (7.5% annualized) hurdle rate measured as of the end of each fiscal quarter, subject to a “catch-up” provision. Under this provision, in any fiscal quarter, our Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. Our Manager will receive 100.0% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter (9.376% annualized); and 20.0% of the amount of the our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter (9.376% annualized).

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20.0% of our “incentive fee capital gains,” which equals our realized capital gains on a cumulative basis from May 31, 2010 through the end of the year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and our Manager will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

For the three months ended November 30, 2014 and 2013, we incurred $1.1 million and $0.9 million in base management fees, respectively. For the three months ended November 30, 2014 and 2013, we accrued $0.7 million and $0.2 million in incentive fees related to pre-incentive fee net investment income. For the three months ended November 30, 2014, we accrued $0.1 million in incentive fees related to capital gains. For the three months ended November 30, 2013, there was a reduction of $0.8 million in incentive management fees related to capital gains. For the nine months ended November 30, 2014 and 2013, we incurred $3.1 million and $2.4 million in base management fees, respectively. For the nine months ended November 30, 2014 and 2013, we accrued $1.6 million and $1.0 million in incentive fees related to pre-incentive fee net investment income. For the nine months ended November 30, 2014, we accrued $0.4 million in incentive management fees related to capital gains. For the nine months ended November 30, 2013, there was a reduction of $0.8 million in incentive management fees related to capital gains. The accrual is calculated using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of November 30, 2014, the base management fees accrual was $1.1 million, and the incentive fees accrual was $3.5 million and is included in management and incentive fees payable in the accompanying consolidated statements of assets and liabilities. As of February 28, 2014, the base management fees accrual was $0.9 million and the incentive fees accrual was $3.0 million and is included in management and incentive fees payable in the accompanying consolidated statements of assets and liabilities.

On July 30, 2010, the Company entered into a separate administration agreement (the “Administration Agreement”) with our Manager, pursuant to which our Manager, as our administrator, has agreed to furnish us with the facilities and administrative services necessary to conduct our day-to-day operations and provide managerial assistance on our behalf to those portfolio companies to which we are required to provide such assistance. The initial term of the Administration Agreement is two years, with automatic, one-year renewals at the end of each year subject to certain approvals by our board of directors and/or our stockholders. The amount of expenses payable or reimbursable thereunder by the Company is capped at $1.0 million for the initial two year term of the administration agreement. On July 10, 2014, our board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to maintain the cap on the payment or reimbursement of expenses by the Company thereunder to $1.0 million for the additional one-year term.

26


Table of Contents

For the three months ended November 30, 2014 and 2013, we recognized $0.3 million and $0.3 million in administrator expenses for the periods, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses, respectively. For the nine months ended November 30, 2014 and 2013, we recognized $0.8 million and $0.8 million in administrator expenses for the periods, pertaining to bookkeeping, record keeping and other administrative services provided to us in addition to our allocable portion of rent and other overhead related expenses, respectively. As of November 30, 2014 and February 28, 2014, $0.3 million and $0.4 million, respectively, of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities.

Note 6. Borrowings

Credit Facility

As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200.0% after giving effect to such leverage. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing.

On April 11, 2007, we entered into a $100.0 million revolving securitized credit facility (the “Revolving Facility”). On May 1, 2007, we entered into a $25.7 million term securitized credit facility (the “Term Facility” and, together with the Revolving Facility, the “Facilities”), which was fully drawn at closing. In December 2007, we consolidated the Facilities by using a draw under the Revolving Facility to repay the Term Facility. In response to the market wide decline in financial asset prices, which negatively affected the value of our portfolio, we terminated the revolving period of the Revolving Facility effective January 14, 2009 and commenced a two-year amortization period during which all principal proceeds from the collateral was used to repay outstanding borrowings. A significant percentage of our total assets had been pledged under the Revolving Facility to secure our obligations thereunder. Under the Revolving Facility, funds were borrowed from or through certain lenders and interest was payable monthly at the greater of the commercial paper rate and our lender’s prime rate plus 4.00% plus a default rate of 2.00% or, if the commercial paper market was unavailable, the greater of the prevailing LIBOR rates and our lender’s prime rate plus 6.00% plus a default rate of 3.00%.

In March 2009, we amended the Revolving Facility to increase the portion of the portfolio that could be invested in “CCC” rated investments in return for an increased interest rate and expedited amortization. As a result of these transactions, we expected to have additional cushion under our borrowing base under the Revolving Facility that would allow us to better manage our capital in times of declining asset prices and market dislocation.

On July 30, 2009, we exceeded the permissible borrowing limit under the Revolving Facility for 30 consecutive days, resulting in an event of default under the Revolving Facility. As a result of this event of default, our lender had the right to accelerate repayment of the outstanding indebtedness under the Revolving Facility and to foreclose and liquidate the collateral pledged thereunder. Acceleration of the outstanding indebtedness and/or liquidation of the collateral could have had a material adverse effect on our liquidity, financial condition and operations.

On July 30, 2010, we used the net proceeds from (i) the stock purchase transaction and (ii) a portion of the funds available to us under the $45.0 million senior secured revolving credit facility (the “Credit Facility”) with Madison Capital Funding LLC to pay the full amount of principal and accrued interest, including default interest, outstanding under the Revolving Facility. As a result, the Revolving Facility was terminated in connection therewith. Substantially all of our total assets, other than those held by SBIC LP, have been pledged under the Credit Facility to secure our obligations thereunder.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

expand the borrowing capacity under the credit facility from $40.0 million to $45.0 million;

extend the period during which we may make and repay borrowings under the credit facility from July 30, 2013 to February 24, 2015 (the “Revolving Period”). The Revolving Period may upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the credit facility are due and payable five years after the end of the Revolving Period; and

remove the condition that we may not acquire additional loan assets without the prior written consent of Madison Capital Funding LLC.

On September 17, 2014, we entered into a second amendment to the Revolving Facility with Madison Capital Funding LLC to, among other things:

extend the commitment termination date from February 24, 2015 to September 17, 2017;

27


Table of Contents
extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.

As of November 30, 2014 and February 28, 2014, there was $4.9 million and $0.0 million outstanding under the Credit Facility, respectively, and the Company was in compliance with all of the limitations and requirements of the Credit Facility. The carrying amount of the amount outstanding under the Credit Facility approximates its fair value. $2.7 million of financing costs related to the Credit Facility have been capitalized and are being amortized over the term of the facility. For the three months ended November 30, 2014 and 2013, we recorded $0.2 million and $0.1 million of interest expense related to the Credit Facility, respectively. For the three months ended November 30, 2014 and 2013, we recorded $0.03 million and $0.1 million of amortization of deferred financing costs related to the Credit Facility, respectively. The interest rates during the three and nine months ended November 30, 2014 on the outstanding borrowings under the Credit Facility were 7.50% and 7.50%, respectively. The interest rates during the three and nine months ended November 30, 2013 on the outstanding borrowings under the Credit Facility were 7.50% and 7.50%, respectively. For the nine months ended November 30, 2014 and 2013, we recorded $0.6 million and $0.8 million of interest expense related to the Credit Facility, respectively. For the nine months ended November 30, 2014 and 2013, we recorded $0.2 million and $0.3 million of amortization of deferred financing costs related to the Credit Facility, respectively.

The Credit Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The Credit Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. The Credit Facility has an eight year term, consisting of a three year period (the “Revolving Period”), under which the Company may make and repay borrowings, and a final maturity five years from the end of the Revolving Period. Availability on the Credit Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50.0% to 75.0% of par or fair value depending on the type of loan asset) and the value of certain “eligible” loan assets included as part of the Borrowing Base. Funds may be borrowed at the greater of the prevailing LIBOR rate and 1.25%, plus an applicable margin of 4.75%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 2.25%, and the applicable margin over such alternative base rate is 3.75%. In addition, the Company will pay the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period.

Our borrowing base under the Credit Facility was $37.1 million subject to the Credit Facility cap of $45.0 million at November 30, 2014 For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the SEC. Accordingly, the November 30, 2014 borrowing base relies upon the valuations set forth in the Annual Report on Form 10-K for the year ended February 28, 2014. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Quarterly Report on Form 10-Q is filed with the SEC.

SBA Debentures

SBIC LP is able to borrow funds from the SBA against regulatory capital (which approximates equity capital) that is paid in and is subject to customary regulatory requirements including but not limited to an examination by the SBA. As of November 30, 2014, we have funded SBIC LP with $59.3 million of equity capital, and have $79.0 million of SBA-guaranteed debentures outstanding. SBA debentures are non-recourse to us, have a 10-year maturity, and may be prepaid at any time without penalty. The interest rate of SBA debentures is fixed at the time of issuance, often referred to as pooling, at a market-driven spread over 10-year U.S. Treasury Notes. SBA current regulations limit the amount that SBIC LP may borrow to a maximum of $150.0 million, which is up to twice its potential regulatory capital.

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $19.5 million and have average annual fully taxed net income not exceeding $6.5 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0% of its investment activity to ‘‘smaller’’ concerns as defined by the SBA. A smaller concern is one that has a tangible net worth not exceeding $6.0 million and has average annual fully taxed net income not exceeding $2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

28


Table of Contents

SBIC LP is subject to regulation and oversight by the SBA, including requirements with respect to maintaining certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that SBIC LP will receive SBA guaranteed debenture funding, which is dependent upon SBIC LP continuing to be in compliance with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to SBIC LP’s assets over our stockholders and debtholders in the event we liquidate SBIC LP or the SBA exercises its remedies under the SBA-guaranteed debentures issued by SBIC LP upon an event of default.

The Company received exemptive relief from the Securities and Exchange Commission to permit it to exclude the debt of SBIC LP guaranteed by the SBA from the definition of senior securities in the 200.0% asset coverage test under the 1940 Act. This allows the Company increased flexibility under the 200.0% asset coverage test by permitting it to borrow up to $150.0 million more than it would otherwise be able to absent the receipt of this exemptive relief.

As of November 30, 2014 and February 28, 2014, there was $79.0 million and $50.0 million outstanding of SBA debentures, respectively. The carrying amount of the amount outstanding of SBA debentures approximates its fair value. $2.7 million of financing costs related to the SBA debentures have been capitalized and are being amortized over the term of the commitment and drawdown. For the three months ended November 30, 2014 and 2013, the Company recorded $0.6 million and $0.3 million, respectively, of interest expense related to the SBA debentures. For the nine months ended November 30, 2014 and 2013, the Company recorded $1.4 million and $0.9 million, respectively, of interest expense related to the SBA debentures. For the three months ended November 30, 2014 and 2013, the Company recorded $0.1 million and $0.05 million, respectively, of amortization of deferred financing costs related to the SBA debentures. For the nine months ended November 30, 2014 and 2013, the Company recorded $0.2 million and $0.2 million, respectively, of amortization of deferred financing costs related to the SBA debentures. The weighted average interest rate during the nine months ended November 30, 2014 and 2013 on the outstanding borrowings of the SBA debentures was 3.16% and 2.99%, respectively.

Notes

On May 10, 2013, the Company issued $42.0 million in aggregate principal amount of 7.50% fixed-rate notes due 2020 (the “Notes”). The Notes will mature on May 31, 2020, and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after May 31, 2016. Interest will be payable quarterly beginning August 15, 2013.

On May 17, 2013, the Company closed an additional $6.3 million in aggregate principal amount of the Notes, pursuant to the full exercise of the underwriters’ option to purchase additional Notes.

As of November 30, 2014, the carrying amount and fair value of the Notes was $48.3 million and $49.5 million, respectively. The fair value of the Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a level 1 liability within the fair value hierarchy. As of November 30, 2014, $2.5 million of financing costs related to the Notes have been capitalized and are being amortized over the term of the Notes. For the three months ended November 30, 2014 and 2013, we recorded $0.9 million and $0.9 million, respectively, of interest expense and $0.1 million and $0.09 million, respectively, of amortization of deferred financing costs related to the Notes. For the nine months ended November 30, 2014 and 2013, we recorded $2.7 million and $2.0 million, respectively, of interest expense and $0.3 million and $0.2 million, respectively, of amortization of deferred financing costs related to the Notes.

Note 7. Commitments and Contingencies

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at November 30, 2014:

Payment Due by Period
Total Less Than
1 Year
1 - 3
Years
3 - 5
Years
More Than
5 Years
($ in thousands)

Long-Term Debt Obligations

$ 132,200 $ $ $ $ 132,200

Off-balance sheet arrangements

The Company’s off-balance sheet arrangements consisted of $12.8 million and $12.2 million of unfunded commitments to provide debt financing to its portfolio companies or to fund limited partnership interests as of November 30, 2014 and February 28, 2014, respectively. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s Consolidated Statement of Assets and Liabilities and are not reflected in the Company’s Consolidated Statements of Assets and Liabilities.

29


Table of Contents

Note 8. Directors Fees

The independent directors receive an annual fee of $40,000. They also receive $2,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and receive $1,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the Audit Committee receives an annual fee of $5,000 and the chairman of each other committee receives an annual fee of $2,000 for their additional services in these capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of net asset value or the market price at the time of payment. No compensation is paid to directors who are “interested persons” of the Company (as such term is defined in the 1940 Act). For the three months ended November 30, 2014 and 2013, we accrued $0.05 million and $0.04 million for directors’ fees expense, respectively. For the nine months ended November 30, 2014 and 2013, we accrued $0.2 million and $0.1 million for directors’ fees expense, respectively. As of November 30, 2014 and February 28, 2014, $0.04 million and $0.05 million in directors’ fees expense were unpaid and included in accounts payable and accrued expenses in the consolidated statements of assets and liabilities. As of November 30, 2014, we had not issued any common stock to our directors as compensation for their services.

Note 9. Stockholders’ Equity

On May 16, 2006, GSC Group, Inc. capitalized the LLC, by contributing $1,000 in exchange for 67 shares, constituting all of the issued and outstanding shares of the LLC.

On March 20, 2007, the Company issued 95,995.5 and 8,136.2 shares of common stock, priced at $150.00 per share, to GSC Group and certain individual employees of GSC Group, respectively, in exchange for the general partnership interest and a limited partnership interest in GSC Partners CDO III GP, LP, collectively valued at $15.6 million. At this time, the 6.7 shares owned by GSC Group in the LLC were exchanged for 6.7 shares of the Company.

On March 28, 2007, the Company completed its IPO of 725,000 shares of common stock, priced at $150.00 per share, before underwriting discounts and commissions. Total proceeds received from the IPO, net of $7.1 million in underwriter’s discount and commissions, and $1.0 million in offering costs, were $100.7 million.

On November 13, 2009, we declared a dividend of $18.25 per share payable on December 31, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $2.50 per share. Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872.5 of newly issued shares of common stock.

On July 30, 2010, our Manager and its affiliates purchased 986,842 shares of common stock at $15.20 per share. Total proceeds received from this sale were $15.0 million.

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

On November 12, 2010, we declared a dividend of $4.40 per share payable on December 29, 2010. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $1.2 million or $0.44 per share. Based on shareholder elections, the dividend consisted of approximately $1.2 million in cash and 596,235 shares of common stock.

On November 15, 2011, we declared a dividend of $3.00 per share payable on December 30, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.0 million or $0.60 per share. Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 599,584 shares of common stock.

On November 9, 2012, the Company declared a dividend of $4.25 per share payable on December 31, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share. Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 853,455 shares of common stock.

30


Table of Contents

On October 30, 2013, the Company declared a dividend of $2.65 per share payable on December 27, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock.

On September 24, 2014, the Company declared a dividend of $0.18 per share payable on November 28, 2014. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock.

On September 24, 2014, the Company announced the approval of an open market share repurchase plan that allows it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published financial statements. As of November 30, 2014, the Company had not purchased any shares of common stock pursuant to this repurchase plan.

Note 10. Earnings Per Share

In accordance with the provisions of FASB ASC 260, “Earnings per Share” (“ASC 260”), basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.

The following information sets forth the computation of the weighted average basic and diluted net increase in net assets per share from operations for the three and nine months ended November 30, 2014 and 2013 (dollars in thousands except share and per share amounts):

For the three months ended For the nine months ended

Basic and diluted

November 30,
2014
November 30,
2013
November 30,
2014
November 30,
2013

Net increase in net assets from operations

$ 3,466 $ 1,268 $ 8,360 $ 5,026

Weighted average common shares outstanding

5,379,616 4,851,451 5,379,616 4,770,267

Earnings per common share-basic and diluted

$ 0.64 $ 0.26 $ 1.55 $ 1.05

Note 11. Dividend

On September 24, 2014, the Company declared a dividend of $0.22 per share payable on February 27, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s DRIP.

On September 24, 2014, the Company declared a dividend of $0.18 per share payable on November 28, 2014. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to the Company’s DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.

On October 30, 2013, the Company declared a dividend of $2.65 per share payable on December 27, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. This dividend was declared in reliance on certain private letter rulings issued by the IRS concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution.

Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13, and 16, 2013.

31


Table of Contents

Note 12. Financial Highlights

The following is a schedule of financial highlights for the nine months ended November 30, 2014 and 2013:

For the nine months ended
November 30,
2014
November 30,
2013

Per share data:

Net asset value at beginning of period

$ 21.36 $ 22.98

Net investment income(1)

1.27 1.60

Net realized and unrealized gains and (losses) on investments and derivatives

0.29 (0.55 )

Net increase in net assets from operations

1.56 1.05

Distributions declared from net investment income

(0.18 ) (2.65 )

Other (2)

(0.71 )

Net asset value at end of period

$ 22.74 $ 20.67

Net assets at end of period

$ 122,315,757 $ 111,206,093

Shares outstanding at end of period

5,379,616 5,379,616

Per share market value at end of period

$ 15.18 $ 15.64

Total return based on market value(3)

(3.55 )% 7.66 %

Total return based on net asset value(4)

7.35 % 5.40 %

Ratio/Supplemental data:

Ratio of net investment income to average, net assets(5)

7.67 % 9.12 %

Ratio of operating expenses to average net assets(5)

6.27 % 5.97 %

Ratio of incentive management fees to average net assets(5)

2.27 % 0.26 %

Ratio of debt related expenses to average net assets(5)

6.13 % 5.18 %

Ratio of total expenses to average net assets(5)

14.66 % 11.42 %

Portfolio turnover rate(6)

22.59 % 36.80 %

(1) Net investment income per share is calculated using the weighted average shares outstanding during the period.
(2) Represents the dilutive effect of issuing common stock below net asset value per share during the period.
(3) Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions. Total investment returns covering less than a full period are not annualized.
(4) Total investment return is calculated assuming a purchase of common shares at the current net asset value on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the Company’s dividend reinvestment plan. Total investment return does not reflect brokerage commissions.
(5) Ratios are annualized.
(6) Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.

Note 13. Subsequent Events

Management has evaluated subsequent events through the date of issuance of the consolidated financial statements included herein. There have been no further subsequent events that occurred during such period that would require disclosure in this

Form 10-Q or would be required to be recognized in the consolidated financial statements as of and for the quarter ended November 30, 2014.

32


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion should be read in conjunction with our financial statements and related notes and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under Part I, Item 1A in our Annual Report on Form 10-K for the fiscal year ended February 28, 2014.

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

The forward-looking statements contained in this Quarterly Report on Form 10-Q involve risks and uncertainties, including statements as to:

our future operating results;

our business prospects and the prospects of our portfolio companies;

the impact of investments that we expect to make;

our contractual arrangements and relationships with third parties;

the dependence of our future success on the general economy and its impact on the industries in which we invest;

the ability of our portfolio companies to achieve their objectives;

our expected financings and investments;

our regulatory structure and tax treatment, including our ability to operate as a business development company, a small business investment company and a regulated investment company;

the adequacy of our cash resources and working capital;

the timing of cash flows, if any, from the operations of our portfolio companies; and

the ability of our investment adviser to locate suitable investments for us and to monitor and effectively administer our investments.

You should not place undue reliance on these forward-looking statements. The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statement to reflect events or circumstances occurring after the date of this Quarterly Report on Form 10-Q.

OVERVIEW

We are a Maryland corporation that has elected to be treated as a business development company (“BDC”) under the Investment Company Act of 1940 (the “1940 Act”). Our investment objective is to generate current income and, to a lesser extent, capital appreciation from our investments. We invest primarily in leveraged loans and mezzanine debt issued by private U.S. middle market companies, which we define as companies having EBITDA of between $5 million and $50 million, both through direct lending and through participation in loan syndicates. We may also invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, which may include securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds. We have elected and qualified to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

Corporate History

We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007 and completed an initial public offering of shares of common stock on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, as described below we engaged Saratoga Investment Advisors (“SIA”) to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

33


Table of Contents

As a result of the event of default under a revolving securitized credit facility with Deutsche Bank we previously had in place, in December 2008 we engaged the investment banking firm of Stifel, Nicolaus & Company to evaluate strategic transaction opportunities and consider alternatives for us. On April 14, 2010, GSC Investment Corp. entered into a stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates and an assignment, assumption and novation agreement with Saratoga Investment Advisors, pursuant to which GSC Investment Corp. assumed certain rights and obligations of Saratoga Investment Advisors under a debt commitment letter Saratoga Investment Advisors received from Madison Capital Funding LLC, which indicated Madison Capital Funding’s willingness to provide GSC Investment Corp. with a $40.0 million senior secured revolving credit facility, subject to the satisfaction of certain terms and conditions. In addition, GSC Investment Corp. and GSCP (NJ), L.P. entered into a termination and release agreement, to be effective as of the closing of the transaction contemplated by the stock purchase agreement, pursuant to which GSCP (NJ), L.P., among other things, agreed to waive any and all accrued and unpaid deferred incentive management fees up to and as of the closing of the transaction contemplated by the stock purchase agreement but continued to be entitled to receive the base management fees earned through the date of the closing of the transaction contemplated by the stock purchase agreement.

On July 30, 2010, the transactions contemplated by the stock purchase agreement with Saratoga Investment Advisors and certain of its affiliates were completed, the private sale of 986,842 shares of our common stock for $15.0 million in aggregate purchase price to Saratoga Investment Advisors and certain of its affiliates closed, the Company entered into the Credit Facility, and the Company began doing business as Saratoga Investment Corp.

We used the net proceeds from the private sale transaction and a portion of the funds available to us under the Credit Facility to pay the full amount of principal and accrued interest, including default interest, outstanding under our revolving securitized credit facility with Deutsche Bank. The revolving securitized credit facility with Deutsche Bank was terminated in connection with our payment of all amounts outstanding thereunder on July 30, 2010.

On August 12, 2010, we effected a one-for-ten reverse stock split of our outstanding common stock. As a result of the reverse stock split, every ten shares of our common stock were converted into one share of our common stock. Any fractional shares received as a result of the reverse stock split were redeemed for cash. The total cash payment in lieu of shares was $230. Immediately after the reverse stock split, we had 2,680,842 shares of our common stock outstanding.

In January 2011, we registered for public resale the 982,842 shares of our common stock issued to Saratoga Investment Advisors and certain of its affiliates.

On March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP (“SBIC LP”), received a Small Business Investment Company (“SBIC”) license from the Small Business Administration (“SBA”).

In May 2013, we issued $48.3 million in aggregate principal amount of our 7.50% unsecured notes due 2020 for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. Interest on these notes is paid quarterly in arrears on February 15, May 15, August 15 and November 15, at a rate of 7.50% per year, beginning August 15, 2013. The notes mature on May 31, 2020 and may be redeemed in whole or in part at any time or from time to time at our option on or after May 31, 2016. The notes are listed on the NYSE under the trading symbol “SAQ” with a par value of $25.00 per share.

Critical Accounting Policies

Basis of Presentation

The preparation of financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make certain estimates and assumptions affecting amounts reported in the Company’s consolidated financial statements. We have identified investment valuation, revenue recognition and the recognition of capital gains incentive fee expense as our most critical accounting estimates. We continuously evaluate our estimates, including those related to the matters described below. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies follows.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurements and Disclosures (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold at the statement of assets and liabilities date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

34


Table of Contents

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from Saratoga Investment Advisers, the audit committee of our board of directors and a third party independent valuation firm. Determinations of fair value may involve subjective judgments and estimates. The types of factors that may be considered in determining the fair value of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flow and other relevant factors. We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

Each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

An independent valuation firm engaged by our board of directors reviews approximately one quarter of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least annually.

In addition, all our investments are subject to the following valuation process:

The audit committee of our board of directors reviews each preliminary valuation and Saratoga Investment Advisors and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

Our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of Saratoga Investment Advisors, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

Our investment in Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”) is carried at fair value, which is based on a discounted cash flow model that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by SIA and recommended to our board of directors. Specifically, we use Intex cash flow models, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The models use a set of assumptions including projected default rates, recovery rates, reinvestment rate and prepayment rates in order to arrive at estimated valuations. The assumptions are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flows analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

Revenue Recognition

Income Recognition

Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortizations of premium on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets , based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

35


Table of Contents

Paid-in-Kind Interest

The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

Capital Gains Incentive Fee

The Company records an expense accrual relating to the capital gains incentive fee payable by the Company to its investment adviser when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the investment adviser if the Company were to liquidate its investment portfolio at such time. The actual incentive fee payable to the Company’s investment adviser related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

Revenues

We generate revenue in the form of interest income and capital gains on the debt investments that we hold and capital gains, if any, on equity interests that we may acquire. We expect our debt investments, whether in the form of leveraged loans or mezzanine debt, to have terms of up to ten years, and to bear interest at either a fixed or floating rate. Interest on debt will be payable generally either quarterly or semi-annually. In some cases, our debt investments may provide for a portion of the interest to be PIK. To the extent interest is paid-in-kind, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation. The principal amount of the debt and any accrued but unpaid interest will generally become due at the maturity date. In addition, we may generate revenue in the form of commitment, origination, structuring or diligence fees, fees for providing managerial assistance or investment management services and possibly consulting fees. Any such fees will be generated in connection with our investments and recognized as earned. We may also invest in preferred equity securities that pay dividends on a current basis.

On January 22, 2008, we entered into a collateral management agreement with Saratoga CLO, pursuant to which we act as its collateral manager. The Saratoga CLO was refinanced in October 2013 and its reinvestment period ends in October 2016. The Saratoga CLO remains 100% owned and managed by Saratoga Investment Corp. We receive a senior collateral management fee of 0.25% and a subordinate collateral management fee of 0.25% of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. We are also entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return equal to or greater than 12.0%.

We recognize interest income on our investment in the subordinated notes of Saratoga CLO using the effective interest method, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Expenses

Our primary operating expenses include the payment of investment advisory and management fees, professional fees, directors and officers insurance, fees paid to independent directors and administrator expenses, including our allocable portion of our administrator’s overhead. Our investment advisory and management fees compensate our investment adviser for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other costs and expenses of our operations and transactions, including those relating to:

organization;

calculating our net asset value (including the cost and expenses of any independent valuation firm);

expenses incurred by our investment adviser payable to third parties, including agents, consultants or other advisers, in monitoring our financial and legal affairs and in monitoring our investments and performing due diligence on our prospective portfolio companies;

interest payable on debt, if any, incurred to finance our investments;

offerings of our common stock and other securities;

36


Table of Contents
investment advisory and management fees;

fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;

transfer agent and custodial fees;

federal and state registration fees;

all costs of registration and listing our common stock on any securities exchange;

federal, state and local taxes;

independent directors’ fees and expenses;

costs of preparing and filing reports or other documents required by governmental bodies (including the SEC and the SBA);

costs of any reports, proxy statements or other notices to common stockholders including printing costs;

our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;

direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the administration agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under an administration agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).

Pursuant to the investment advisory and management agreement that we had with GSCP (NJ), L.P., our former investment adviser and administrator, we had agreed to pay GSCP (NJ), L.P. as investment adviser a quarterly base management fee of 1.75% of the average value of our total assets (other than cash or cash equivalents but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters, and appropriately adjusted for any share issuances or repurchases during the applicable fiscal quarter, and an incentive fee.

The incentive fee had two parts:

A fee, payable quarterly in arrears, equal to 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of the net assets at the end of the immediately preceding quarter, that exceeded a 1.875% quarterly (7.5% annualized) hurdle rate measured as of the end of each fiscal quarter. Under this provision, in any fiscal quarter, our investment adviser received no incentive fee unless our pre-incentive fee net investment income exceeded the hurdle rate of 1.875%. Amounts received as a return of capital were not included in calculating this portion of the incentive fee. Since the hurdle rate was based on net assets, a return of less than the hurdle rate on total assets could still have resulted in an incentive fee.

A fee, payable at the end of each fiscal year, equal to 20.0% of our net realized capital gains, if any, computed net of all realized capital losses and unrealized capital depreciation, in each case on a cumulative basis, less the aggregate amount of capital gains incentive fees paid to the investment adviser through such date.

We deferred cash payment of any incentive fee otherwise earned by our former investment adviser if, during the then most recent four full fiscal quarters ending on or prior to the date such payment was to be made, the sum of (a) our aggregate distributions to our stockholders and (b) our change in net assets (defined as total assets less liabilities) (before taking into account any incentive fees payable during that period) was less than 7.5% of our net assets at the beginning of such period. These calculations were appropriately pro-rated for the first three fiscal quarters of operation and adjusted for any share issuances or repurchases during the applicable period. Such incentive fee would become payable on the next date on which such test had been satisfied for the most recent four full fiscal quarters or upon certain terminations of the investment advisory and management agreement. We commenced deferring cash payment of incentive fees during the quarterly period ended August 31, 2007, and continued to defer such payments through the quarterly period ended May 31, 2010. As of July 30, 2010, the date on which GSCP (NJ), L.P. ceased to be our investment adviser and administrator, we owed GSCP (NJ), L.P. $2.9 million in fees for services previously provided to us; of which $0.3 million has been paid by us. GSCP (NJ), L.P. agreed to waive payment by us of the remaining $2.6 million in connection with the consummation of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates described elsewhere in this Annual Report.

37


Table of Contents

The terms of the investment advisory and management agreement with Saratoga Investment Advisors, our current investment adviser, are substantially similar to the terms of the investment advisory and management agreement we had entered into with GSCP (NJ), L.P., our former investment adviser, except for the following material distinctions in the fee terms:

The capital gains portion of the incentive fee was reset with respect to gains and losses from May 31, 2010, and therefore losses and gains incurred prior to such time will not be taken into account when calculating the capital gains fee payable to Saratoga Investment Advisors and, as a result, Saratoga Investment Advisors will be entitled to 20.0% of net gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 equal the fair value of such investment as of such date. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P., the capital gains fee was calculated from March 21, 2007, and the gains were substantially outweighed by losses.

Under the “catch up” provision, 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income that exceeds 1.875% (7.5% annualized) but is less than or equal to 2.344% in any fiscal quarter is payable to Saratoga Investment Advisors. This will enable Saratoga Investment Advisors to receive 20.0% of all net investment income as such amount approaches 2.344% in any quarter, and Saratoga Investment Advisors will receive 20.0% of any additional net investment income. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P. only received 20.0% of the excess net investment income over 1.875%.

We will no longer have deferral rights regarding incentive fees in the event that the distributions to stockholders and change in net assets is less than 7.5% for the preceding four fiscal quarters.

To the extent that any of our leveraged loans are denominated in a currency other than U.S. dollars, we may enter into currency hedging contracts to reduce our exposure to fluctuations in currency exchange rates. We may also enter into interest rate hedging agreements. Such hedging activities, which will be subject to compliance with applicable legal requirements, may include the use of interest rate caps, futures, options and forward contracts. Costs incurred in entering into or settling such contracts will be borne by us.

Portfolio and investment activity

Corporate Debt Portfolio Overview

At November 30,
2014
At February 28,
2014
($ in millions)

Number of investments(1)

60 59

Number of portfolio companies(1)

36 37

Average investment size(1)

$ 3.7 $ 3.2

Weighted average maturity(1)

3.8 yrs 4.3 yrs

Number of industries(1)

15 16

Average investment per portfolio company(1)

$ 6.2 $ 5.0

Non-performing or delinquent investments(1)

$ 6.0 $ 0.3

Fixed rate debt (% of interest bearing portfolio)(2)

$ 86.7(40.8 )% $ 70.6(40.1 )%

Weighted average current coupon(2)

11.3 % 12.5 %

Floating rate debt (% of interest bearing portfolio)(2)

$ 125.8(59.2 )% $ 105.4(59.9 )%

Weighted average current spread over LIBOR(2)

8.7 % 7.3 %

(1) Excludes our investment in the subordinated notes of Saratoga CLO.
(2) Excludes our investment in the subordinated notes of Saratoga CLO and investments in common stocks.

During the three months ended November 30, 2014, we made $30.6 million investments in new or existing portfolio companies and had $26.8 million in aggregate amount of exits and repayments resulting in net investments of $3.8 million for the period. During the three months ended November 30, 2013, we made $22.3 million investments in the new or existing portfolio companies and had $9.9 million in aggregate amount of exits and repayments resulting in net investments of $12.4 million for the period.

During the nine months ended November 30, 2014, we made $84.0 million investments in new or existing portfolio companies and had $51.2 million in aggregate amount of exits and repayments resulting in net investments of $32.8 million for the period. During the nine months ended November 30, 2013, we made $110.1 million investments in new or existing portfolio companies and had $65.0 million in aggregate amount of exits and repayments resulting in net investments of $45.1 million for the period.

38


Table of Contents

Our portfolio composition based on fair value at November 30, 2014 and February 28, 2014 was as follows:

Portfolio composition

At November 30, 2014 At February 28, 2014
Percentage
of Total
Portfolio
Weighted
Average
Current
Yield
Percentage
of Total
Portfolio
Weighted
Average
Current
Yield

Syndicated loans

10.2 % 6.4 % 15.7 % 6.2 %

First lien term loans

50.0 11.3 39.0 10.7

Second lien term loans

15.2 11.3 13.5 11.1

Senior secured notes

10.3 8.8 14.6 13.8

Unsecured notes

2.5 14.2 2.7 15.2

Saratoga CLO subordinated notes

8.0 27.6 9.5 18.6

Equity interests

3.8 N/A 5.0 N/A

Total

100.0 % 11.9 % 100.0 % 11.8 %

Our investment in the subordinated notes of Saratoga CLO represents a first loss position in a portfolio that, at November 30, 2014 and February 28, 2014, was composed of $302.6 million and $301.3 million, respectively, in aggregate principal amount of predominantly senior secured first lien term loans. This investment is subject to unique risks. (See “Risk Factors—Our investment in Saratoga CLO 2013-1 Ltd. constitutes a leveraged investment in a portfolio of predominantly senior secured first lien term loans and is subject to additional risks and volatility” in our Annual Report on Form 10-K for the fiscal year ended February 28, 2014.). We do not consolidate the Saratoga CLO portfolio in our financial statements. Accordingly, the metrics below do not include the underlying Saratoga CLO portfolio investments. However, at November 30, 2014, $289.3 million or 97.4% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and one Saratoga CLO portfolio investment was in default. At February 28, 2014, $298.9 million or 99.5% of the Saratoga CLO portfolio investments in terms of market value had a CMR color rating of green or yellow and no Saratoga CLO portfolio investments were in default.

Saratoga Investment Advisors normally grades all of our investments using a credit and monitoring rating system (“CMR”). The CMR consists of a single component: a color rating. The color rating is based on several criteria, including financial and operating strength, probability of default, and restructuring risk. The color ratings are characterized as follows: (Green)—strong credit; (Yellow)—satisfactory credit; (Red)—payment default risk, in payment default and/or significant restructuring activity.

The CMR distribution of our investments at November 30, 2014 and February 28, 2014 was as follows:

Portfolio CMR distribution

At November 30, 2014 At February 28, 2014

Color

Score

Investments
at
Fair Value
Percentage
of
Total
Portfolio
Investments
at
Fair Value
Percentage
of
Total
Portfolio
($ in thousands)

Green

$ 196,496 81.5 % $ 159,207 77.4 %

Yellow

8,339 3.4 8,466 4.1

Red

7,680 3.2 8,270 4.0

N/A(1)

28,658 11.9 29,902 14.5

Total

$ 241,173 100.0 % $ 205,845 100.0 %

(1) Comprised of our investment in the subordinated notes of Saratoga CLO and equity interests.

39


Table of Contents

The CMR distribution of Saratoga CLO investments at November 30, 2014 and February 28, 2014 was as follows:

Portfolio CMR distribution

At November 30, 2014 At February 28, 2014

Color

Score

Investments
at
Fair Value
Percentage
of
Total
Portfolio
Investments
at
Fair Value
Percentage
of
Total
Portfolio
($ in thousands)

Green

$ 281,295 94.7 % $ 284,796 94.8 %

Yellow

7,982 2.7 14,106 4.7

Red

7,762 2.6 1,589 0.5

Total

$ 297,039 100.0 % $ 300,491 100.0 %

Portfolio composition by industry grouping at fair value

The following table shows the portfolio composition by industry grouping at fair value at November 30, 2014 and February 28, 2014:

At November 30, 2014 At February 28, 2014
Investments
at
Fair Value
Percentage
of
Total
Portfolio
Investments
at
Fair Value
Percentage
of
Total
Portfolio
($ in thousands)

Software

$ 49,033 20.3 % $ 21,738 10.5 %

Business Services

45,596 18.9 57,330 27.9

Healthcare Services

34,431 14.3 23,810 11.6

Consumer Services

27,862 11.6 21,897 10.6

Structured Finance Securities(1)

19,433 8.1 19,570 9.5

Automotive Aftermarket

10,717 4.4 10,621 5.2

Food and Beverage

10,369 4.3 17,286 8.4

Media

9,844 4.1

Electronics

6,471 2.7 6,741 3.3

Utilities

6,105 2.5

Metals

6,020 2.5 6,645 3.2

Manufacturing

5,925 2.5 5,970 2.9

Consumer Products

5,312 2.2 6,118 3.0

Building Products

2,395 1.0 901 0.4

Publishing

1,559 0.6 1,191 0.6

Education

101 0.0 90 0.0

Environmental

5,249 2.5

Homebuilding

344 0.2

Aerospace

344 0.2

Total

$ 241,173 100.0 % $ 205,845 100.0 %

(1) Comprised of our investment in the subordinated notes of Saratoga CLO.

40


Table of Contents

The following table shows the portfolio composition by industry grouping of Saratoga CLO at fair value at November 30, 2014 and February 28, 2014:

At November 30, 2014 At February 28, 2014
Investments
at
Fair Value
Percentage
of Total
Portfolio
Investments
at
Fair Value
Percentage
of Total
Portfolio
($ in thousands)

Business Equipment and Services

$ 37,967 12.8 % $ 28,386 9.4 %

Healthcare

37,054 12.5 37,896 12.6

Chemicals/Plastics

27,244 9.2 26,345 8.8
Retailers (Except Food and Drugs) 20,008 6.7 15,314 5.1

Conglomerate

19,939 6.7 24,285 8.1

Industrial Equipment

15,374 5.2 24,143 8.0

Electronics/Electric

12,863 4.3 11,861 4.0

Leisure Goods/Activities/Movies

12,726 4.2 8,990 3.0

Financial Intermediaries

10,753 3.6 8,138 2.7

Drugs

10,115 3.4 11,873 4.0

Food Services

8,472 2.9 5,612 1.9

Aerospace and Defense

7,281 2.5 20,465 6.8

Oil and Gas

6,872 2.3 2,488 0.8

Telecommunications

6,651 2.2 6,627 2.2

Automotive

6,640 2.2 10,279 3.4

Containers/Glass Products

6,353 2.1 2,906 1.0

Utilities

6,212 2.1 5,830 1.9

Lodging and Casinos

5,847 2.0 499 0.2

Food Products

5,809 2.0 12,450 4.1

Food/Drug Retailers

5,773 1.9 5,012 1.7

Publishing

5,628 1.9 2,913 1.0

Insurance

5,427 1.8 5,517 1.8

Brokers/Dealers/Investment Houses

4,881 1.6 3,740 1.2

Cable and Satellite Television

2,624 0.9 2,666 0.9

Telecommunications/Cellular

2,431 0.8 2,460 0.8

Media

2,005 0.7 1,000 0.3

Nonferrous Metals/Minerals

1,849 0.6 4,328 1.4

Ecological Services and Equipment

826 0.3 1,241 0.4

Building and Development

484 0.2 3,246 1.1

Broadcast Radio and Television

475 0.2 1,505 0.5

Health Insurance

456 0.2

Computers and Electronics

1,479 0.5

Gaming and Hotels

500 0.2

Leasing

497 0.2

Total

$ 297,039 100.0 % $ 300,491 100.0 %

Portfolio composition by geographic location at fair value

The following table shows the portfolio composition by geographic location at fair value at November 30, 2014 and February 28, 2014. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

At November 30, 2014 At February 28, 2014
Investments
at
Fair Value
Percentage
of Total
Portfolio
Investments
at
Fair Value
Percentage
of Total
Portfolio
($ in thousands)

Southeast

$ 95,893 39.8 % $ 83,161 40.4 %

Midwest

43,031 17.8 41,453 20.1

Northeast

42,779 17.7 17,191 8.4

West

40,037 16.6 44,470 21.6

Other(1)

19,433 8.1 19,570 9.5

Total

$ 241,173 100.0 % $ 205,845 100.0 %

(1) Comprised of our investment in the subordinated notes of Saratoga CLO.

41


Table of Contents

Results of operations

Operating results for the three and nine months ended November 30, 2014 and 2013 are as follows:

For the three months ended
November 30, 2014 November 30, 2013
($ in thousands)

Total investment income

$ 7,305 $ 5,801

Total expenses, net

4,595 2,903

Net investment income

2,710 2,898

Net realized gains

2,761 83

Net unrealized losses

(2,005 ) (1,713 )

Net increase in net assets resulting from operations

$ 3,466 $ 1,268

For the nine months ended
November 30, 2014 November 30, 2013
($ in thousands)

Total investment income

$ 19,924 $ 17,206

Total expenses, net

13,081 9,567

Net investment income

6,843 7,639

Net realized gains

3,203 1,158

Net unrealized losses

(1,686 ) (3,771 )

Net increase in net assets resulting from operations

$ 8,360 $ 5,026

Investment income

The composition of our investment income for the three and nine months ended November 30, 2014 and 2013 was as follows:

For the three months ended
November 30, 2014 November 30, 2013
($ in thousands)

Interest from investments

$ 6,054 $ 4,997

Management fee income from Saratoga CLO

383 421

Interest from cash and cash equivalents and other income

868 383

Total investment income

$ 7,305 $ 5,801

For the nine months ended
November 30, 2014 November 30, 2013
($ in thousands)

Interest from investments

$ 17,693 $ 14,961

Management fee income from Saratoga CLO

1,150 1,400

Interest from cash and cash equivalents and other income

1,081 845

Total investment income

$ 19,924 $ 17,206

42


Table of Contents

For the three months ended November 30, 2014, total investment income increased $1.5 million, or 25.9% compared to the three months ended November 30, 2013. Interest income from investments increased $1.1 million, or 21.2%, to $6.1 million for the three months ended November 30, 2014, from $5.0 million for the three months ended November 30, 2013. This reflects an increase of 21.3% in total investments to $241.2 million at November 30, 2014 from $198.8 million at November 30, 2013, with the weighted average yield also increasing to 11.9% from 10.8%. In addition, other income increased $0.5 million, or 127.4% from $0.4 million for the three months ended November 30, 2013 to $0.9 million for the three months ended November 30, 2014, reflecting the receipt of an increased number of dividends during those three months.

For the nine months ended November 30, 2014, total investment income increased $2.7 million, or 15.8%, compared to the nine months ended November 30, 2013. Interest income from investments increased $2.7 million, or 18.3%, to $17.7 million for the nine months ended November 30, 2014, from $15.0 million for the nine months ended November 30, 2013. This reflects an increase of 21.3% in total investments to $241.2 million at November 30, 2014 from $198.8 million at November 30, 2013, with the weighted average yield also increasing to 11.9% from 10.8%.

For the three and nine months ended November 30, 2014 and 2013, total PIK income was $0.3 million and $0.9 million, and $0.2 million and $0.6 million, respectively.

The Saratoga CLO was refinanced in October 2013. As a result, proceeds from principal payments in the loan portfolio of Saratoga CLO must now be used to paydown its outstanding notes. Thus, the management fee income and investment income that we receive from Saratoga CLO has declined from historical periods decreasing $0.04 million, or 9.0%, to $0.4 million and $0.2 million, or 17.9%, to $1.2 million, respectively, for the three and nine months ended November 30, 2014 from $0.4 million and $1.4 million for the three and nine months ended November 30, 2013, respectively.

Operating expenses

The composition of our expenses for the three and nine months ended November 30, 2014 and 2013 was as follows:

Operating Expenses

For the three months ended
November 30, 2014 November 30, 2013
($ in thousands)

Interest and debt financing expenses

$ 1,869 $ 1,611

Base management fees

1,088 876

Professional fees

226 313

Incentive management fees

852 (561 )

Administrator expenses

250 250

Insurance

83 118

Directors fees and expenses

51 36

General and administrative and other expenses

176 260

Total expenses

$ 4,595 $ 2,903

For the nine months ended
November 30, 2014 November 30, 2013
($ in thousands)

Interest and debt financing expenses

$ 5,466 $ 4,343

Base management fees

3,093 2,424

Professional fees

937 879

Incentive management fees

2,022 220

Administrator expenses

750 750

Insurance

252 357

Directors fees and expenses

160 132

General and administrative and other expenses

401 462

Total expenses

$ 13,081 $ 9,567

For the three months ended November 30, 2014, total operating expenses increased $1.7 million, or 58.3% compared to the three months ended November 30, 2013. For the nine months ended November 30, 2014, total operating expenses increased $3.5 million or 36.7% compared to the nine months ended November 30, 2013.

43


Table of Contents

For the three months ended November 30, 2014 and 2013, the increase in interest and credit facility expense is primarily attributable to an increase in the amount of outstanding debt as compared to the prior periods, with higher levels of both the SBA debentures and the revolving credit facility outstanding. For the three months ended November 30, 2014, the weighted average interest rate on our outstanding indebtedness was 4.97% compared to 5.55% for the three months ended November 30, 2013. This decrease was primarily driven by an increase in SBA debentures that carry a lower interest rate but now make up a higher proportion of our overall debt, increasing from 43.3% of overall debt as of November 30, 2013 to 59.8% as of November 30, 2014.

For the nine months ended November 30, 2014 and 2013, the increase in interest and credit facility expense is primarily attributable to an increase in the amount of outstanding debt as compared to the prior periods, with increased levels of both the SBA debentures and the revolving credit facility outstanding. For the nine months ended November 30, 2014, the weighted average interest rate on our outstanding indebtedness was 5.13% for both the nine months ended November 30, 2013 and 2014.

For the three months ended November 30, 2014, base management fees increased $0.2 million, or 24.2% compared to the three months ended November 30, 2013. For the nine months ended November 30, 2014, base management fees increased $0.7 million, or 27.6% compared to the nine months ended November 30, 2013. The increase in base management fees results from the increase in the average value of our total assets, less cash and cash equivalents, from $200.9 million to $246.6 million as of November 30, 2013 and 2014, respectively.

For the three and nine months ended November 30, 2014, professional fees decreased $0.1 million or 27.8%, and increased $0.1 million, or 6.6%, respectively, compared to the three and nine months ended November 30, 2013.

For the three months ended November 30, 2014, incentive management fees increased $1.4 million compared to the three months ended November 30, 2013. For the three months ended November 30, 2014 incentive management fees were $0.9 million. For the three months ended November 30, 2013 there was a reduction of $0.5 million in incentive management fees which was related to capital losses, thereby offsetting incentive fees expense related to investment income. For the nine months ended November 30, 2014, incentive management fees increased $1.8 million or 819.1% compared to the nine months ended November 30, 2013. The increase in incentive management fees is primarily attributable to an increase in accrued incentive fees related to higher net investment income and incentive fee capital gains, offset by incentive management fee credits for the three months ended November 30, 2013, driven by net unrealized losses in that period .

As discussed above, the increase in interest and credit facility expense for the three and nine months ended November 30, 2014 and 2013 is primarily attributable to an increase in the amount of outstanding debt as compared to the prior periods. For the nine months ended November 30, 2014, the weighted average interest rate on the outstanding borrowings under the Credit Facility and notes payable was 7.50%, however the notes were only issued and outstanding from May 10, 2013, while they were outstanding for the full nine months ended November 30, 2014. For the three months ended November 30, 2014 and 2013, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.16% and 3.16%, respectively. For the nine months ended November 30, 2014 and 2013, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.16% and 2.99%, respectively.

Net realized gains/losses on sales of investments

For the three months ended November 30, 2014, the Company had $26.8 million of sales, repayments, exits or restructurings resulting in $2.8 million of net realized gains.

For the nine months ended November 30, 2014, the Company had $51.2 million of sales, repayments, exits or restructurings resulting in $3.2 million of net realized gains.

For the three months ended November 30, 2013, the Company had $9.9 million of sales, repayments, exits or restructurings resulting in $0.1 million of net realized gains.

For the nine months ended November 30, 2013, the Company had $65.0 million of sales, repayments, exits or restructurings resulting in $1.2 million of net realized gains.

Net unrealized appreciation/depreciation on investments

For the three months ended November 30, 2014, our investments had net unrealized depreciation of $2.0 million versus net unrealized depreciation of $1.7 million for the three months ended November 30, 2013. For the nine months ended November 30, 2014, our investments had net unrealized depreciation of $1.7 million versus net unrealized depreciation of $3.8 million for the nine months ended November 30, 2013. The most significant cumulative changes in unrealized appreciation and depreciation for the nine months ended November 30, 2014, were the following:

44


Table of Contents

Nine Months ended November 30, 2014

Issuer

Asset Type

Cost Fair
Value
Total
Unrealized
Appreciation/
(Depreciation)
YTD Change
in Unrealized
Appreciation/
(Depreciation)
($ in thousands)

Elyria Foundry Company, L.L.C.

Senior Secured Note $ 8,860 $ 6,020 $ (2,840 ) $ (624 )

Legacy Cabinets Holdings

Common A-1 221 1,468 1,247 916

Targus Holdings, Inc.

Common 567 (567 ) (730 )

The $0.6 million of unrealized depreciation in our investment in Elyria Foundry Company, LLC was due to a decline in the company’s performance as a result of volume declines from key energy customers.

The $0.9 million of unrealized appreciation in our investment in Legacy Cabinets, Inc. was driven by significant fundamental growth, which increased the fair market value of the equity.

The $0.7 million of unrealized depreciation in our investment in Targus Holdings, Inc. was due to a decline in earnings resulting from weakened demand in the company’s end markets.

The most significant cumulative changes in unrealized appreciation and depreciation for the nine months ended November 30, 2013, were the following:

Nine months ended November 30, 2013

Issuer

Asset Type

Cost Fair
Value
Total
Unrealized
Appreciation/
(Depreciation)
YTD Change
in Unrealized
Appreciation/
(Depreciation)
($ in thousands)

Elyria Foundry Company, L.L.C.

Senior Secured Note $ 8,860 $ 6,685 $ 2,175 $ (2,174 )

Saratoga CLO

Other/ Structured Finance Securities 16,555 19,019 2,464 (4,109 )

USS Parent Holding Corp.

Voting Common Stock 3,026 4,381 1,355 1,515

The $2.2 million of unrealized depreciation in our investment in Elyria Foundry Company, LLC was due to a weakened demand in oil and gas end-markets.

The $4.1 million of unrealized depreciation in our investment in the Saratoga CLO subordinated notes was due to lower net present value of projected future cash flows due to a smaller total portfolio and higher financing costs.

The $1.5 million of unrealized appreciation in our investment in the common stock of USS Parent Holding Corp. was due to improved operating performance.

Changes in net assets resulting from operations

For the three months ended November 30, 2014, we recorded a net increase in net assets resulting from operations of $3.5 million versus a net increase in net assets resulting from operations of $1.3 million for the three months ended November 30, 2013. Based on 5,379,616 and 4,851,451 weighted average common shares outstanding for the three months ended November 30, 2014 and November 30, 2013, respectively, our per share net increase in net assets resulting from operations was $0.64 for the three months ended November 30, 2014 versus a per share net increase in net assets from operations of $0.26 for the three months ended November 30, 2013.

For the nine months ended November 30, 2014, we recorded a net increase in net assets resulting from operations of $8.4 million versus a net increase in net assets resulting from operations of $5.0 million for the nine months ended November 30, 2013. Based on 5,379,616 and 4,770,267 weighted average common shares outstanding for the nine months ended November 30, 2014 and November 30, 2013, respectively, our per share net increase in net assets resulting from operations was $1.55 for the nine months ended November 30, 2014 versus a per share net increase in net assets from operations of $1.05 for the nine months ended November 30, 2013.

45


Table of Contents

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

We intend to continue to generate cash primarily from cash flows from operations, including interest earned from our investments in debt in middle market companies, interest earned from the temporary investment of cash in U.S. government securities and other high-quality debt investments that mature in one year or less, future borrowings and future offerings of securities.

Although we expect to fund the growth of our investment portfolio through the net proceeds from SBA debenture drawdowns and future equity offerings, including our dividend reinvestment plan, and issuances of senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure you that our plans to raise capital will be successful. In this regard, because our common stock has historically traded at a price below our current net asset value per share and we are limited in our ability to sell our common stock at a price below net asset value per share, we have been and may continue to be limited in our ability to raise equity capital. Our stockholders approved a proposal at our annual meeting of stockholders held on September 30, 2014 that authorizes us to sell shares of our common stock at an offering price per share to investors that is not less than 85% of our then current net asset value per share in one or more offerings for a period ending on the earlier of September 30, 2015 or the date of our next annual meeting of stockholders. We would need stockholder approval of a similar proposal to issue shares below net asset value per share at any time after the earlier of September 30, 2015 or our next annual meeting of stockholders.

In addition, we intend to distribute to our stockholders substantially all of our taxable income in order to satisfy the distribution requirement applicable to RICs under Subchapter M of the Code. In satisfying this distribution requirement, we have in the past relied on IRS issued private letter rulings concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20% of the aggregate declared distribution. We may rely on these IRS private letter rulings in future periods to satisfy our RIC distribution requirement.

Also, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 200%. This requirement limits the amount that we may borrow. Our asset coverage ratio, as defined in the 1940 Act, was 329.9% as of November 30, 2014 and 337.9% as of February 28, 2014. To fund growth in our investment portfolio in the future, we anticipate needing to raise additional capital from various sources, including the equity markets and other debt-related markets, which may or may not be available on favorable terms, if at all.

Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies or to repay borrowings. Also, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.

Madison revolving credit facility

Below is a summary of the terms of the senior secured revolving credit facility we entered into with Madison Capital Funding (the “Credit Facility”) on June 30, 2010.

Availability. The Company can draw up to the lesser of (i) $40.0 million (the “Facility Amount”) and (ii) the product of the applicable advance rate (which varies from 50.0% to 75.0% depending on the type of loan asset) and the value, determined in accordance with the Credit Facility (the “Adjusted Borrowing Value”), of certain “eligible” loan assets pledged as security for the loan (the “Borrowing Base”), in each case less (a) the amount of any undrawn funding commitments the Company has under any loan asset and which are not covered by amounts in the Unfunded Exposure Account referred to below (the “Unfunded Exposure Amount”) and (b) outstanding borrowings. Each loan asset held by the Company as of the date on which the Credit Facility was closed was valued as of that date and each loan asset that the Company acquires after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.

The Credit Facility contains limitations on the type of loan assets that are “eligible” to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an “eligible” loan asset, the Company may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially adverse to the lenders.

46


Table of Contents

Collateral. The Credit Facility is secured by substantially all of the assets of the Company (other than assets held by our SBIC subsidiary) and includes the subordinated notes (“CLO Notes”) issued by Saratoga CLO and the Company’s rights under the CLO Management Agreement (as defined below).

Interest Rate and Fees. Under the Credit Facility, funds are borrowed from or through certain lenders at the greater of the prevailing LIBOR rate and 2.00%, plus an applicable margin of 5.50%. At the Company’s option, funds may be borrowed based on an alternative base rate, which in no event will be less than 3.00%, and the applicable margin over such alternative base rate is 4.50%. In addition, the Company pays the lenders a commitment fee of 0.75% per year on the unused amount of the Credit Facility for the duration of the Revolving Period (defined below). Accrued interest and commitment fees are payable monthly. The Company was also obligated to pay certain other fees to the lenders in connection with the closing of the Credit Facility.

Revolving Period and Maturity Date. The Company may make and repay borrowings under the Credit Facility for a period of three years following the closing of the Credit Facility (the “Revolving Period”). The Revolving Period may be terminated at an earlier time by the Company or, upon the occurrence of an event of default, by action of the lenders or automatically. All borrowings and other amounts payable under the Credit Facility are due and payable in full five years after the end of the Revolving Period.

Collateral Tests. It is a condition precedent to any borrowing under the Credit Facility that the principal amount outstanding under the Credit Facility, after giving effect to the proposed borrowings, not exceed the lesser of the Borrowing Base or the Facility Amount (the “Borrowing Base Test”). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the “Collateral Tests”):

Interest Coverage Ratio. The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Credit Facility, to accrued interest and commitment fees and any breakage costs payable to the lenders under the Credit Facility for the last 6 payment periods must equal at least 175.0%.

Overcollateralization Ratio. The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets plus the fair value of certain ineligible pledged loan assets and the CLO Notes (in each case, subject to certain adjustments) to outstanding borrowings under the Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

Weighted Average FMV Test. The aggregate adjusted or weighted value of “eligible” pledged loan assets as a percentage of the aggregate outstanding principal balance of “eligible” pledged loan assets must be equal to or greater than 72.0% and 80.0% during the one-year periods prior to the first and second anniversary of the closing date, respectively, and 85.0% at all times thereafter.

The Credit Facility also requires payment of outstanding borrowings or replacement of pledged loan assets upon the Company’s breach of its representation and warranty that pledged loan assets included in the Borrowing Base are “eligible” loan assets. Such payments or replacements must equal the lower of the amount by which the Borrowing Base is overstated as a result of such breach or any deficiency under the Collateral Tests at the time of repayment or replacement. Compliance with the Collateral Tests is also a condition to the discretionary sale of pledged loan assets by the Company.

Priority of Payments. During the Revolving Period, the priority of payments provisions of the Credit Facility require, after payment of specified fees and expenses and any necessary funding of the Unfunded Exposure Account, that collections of principal from the loan assets and, to the extent that these are insufficient, collections of interest from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met. Similarly, following termination of the Revolving Period, collections of interest are required to be applied, after payment of certain fees and expenses, to cure any deficiencies in the Borrowing Base Test, the Interest Coverage Ratio and the Overcollateralization Ratio as of the relevant payment date.

Reserve Account. The Credit Facility requires the Company to set aside an amount equal to the sum of accrued interest, commitment fees and administrative agent fees due and payable on the next succeeding three payment dates (or corresponding to three payment periods). If for any monthly period during which fees and other payments accrue, the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets which do not pay cash interest at least quarterly exceeds 15.0% of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets, the Company is required to set aside such interest and fees due and payable on the next succeeding six payment dates. Amounts in the reserve account can be applied solely to the payment of administrative agent fees, commitment fees, accrued and unpaid interest and any breakage costs payable to the lenders.

Unfunded Exposure Account. With respect to revolver or delayed draw loan assets, the Company is required to set aside in a designated account (the “Unfunded Exposure Account”) 100.0% of its outstanding and undrawn funding commitments with respect to such loan assets. The Unfunded Exposure Account is funded at the time the Company acquires a revolver or delayed draw loan asset and requests a related borrowing under the Credit Facility. The Unfunded Exposure Account is funded through a combination of proceeds of the requested borrowing and other Company funds, and if for any reason such amounts are insufficient, through application of the priority of payment provisions described above.

47


Table of Contents

Operating Expenses. The priority of payments provision of the Credit Facility provides for the payment of certain operating expenses of the Company out of collections on principal and interest during the Revolving Period and out of collections on interest following the termination of the Revolving Period in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $350,000 for each monthly payment date or $2.5 million for the immediately preceding period of twelve consecutive monthly payment dates. This ceiling can be increased by the lesser of 5.0% or the percentage increase in the fair market value of all the Company’s assets only on the first monthly payment date to occur after each one-year anniversary following the closing of the Credit Facility. Upon the occurrence of a Manager Event (described below), the consent of the administrative agent is required in order to pay operating expenses through the priority of payments provision.

Events of Default. The Credit Facility contains certain negative covenants, customary representations and warranties and affirmative covenants and events of default. The Credit Facility does not contain grace periods for breach by the Company of certain covenants, including, without limitation, preservation of existence, negative pledge, change of name or jurisdiction and separate legal entity status of the Company covenants and certain other customary covenants. Other events of default under the Credit Facility include, among other things, the following:

an Interest Coverage Ratio of less than 150.0%;

an Overcollateralization Ratio of less than 175.0%;

the filing of certain ERISA or tax liens;

the occurrence of certain “Manager Events” such as:

failure by Saratoga Investment Advisors and its affiliates to maintain collectively, directly or indirectly, a cash equity investment in the Company in an amount equal to at least $5,000,000 at any time prior to the third anniversary of the closing date;

failure of the Management Agreement between Saratoga Investment Advisors and the Company to be in full force and effect;

indictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed to replace such key person within 30 days;

resignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in Saratoga Investment Advisors’ daily activities, all without a reputable, experienced individual reasonably satisfactory to Madison Capital Funding appointed within 30 days; or

occurrence of any event constituting “cause” under the Collateral Management Agreement between the Company and Saratoga CLO (the “CLO Management Agreement”), delivery of a notice under Section 12(c) of the CLO Management Agreement with respect to the removal of the Company as collateral manager or the Company ceases to act as collateral manager under the CLO Management Agreement.

Conditions to Acquisitions and Pledges of Loan Assets. The Credit Facility imposes certain additional conditions to the acquisition and pledge of additional loan assets. Among other things, the Company may not acquire additional loan assets without the prior written consent of the administrative agent until such time that the administrative agent indicates in writing its satisfaction with Saratoga Investment Advisors’ policies, personnel and processes relating to the loan assets.

Fees and Expenses. The Company paid certain fees and reimbursed Madison Capital Funding for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Madison Capital Funding in connection with the Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates. These amounts totaled $2.0 million.

On February 24, 2012, we amended our senior secured revolving credit facility with Madison Capital Funding LLC to, among other things:

expand the borrowing capacity under the credit facility from $40.0 million to $45.0 million;

48


Table of Contents
extend the Revolving Period from July 30, 2013 to February 24, 2015; and

remove the condition that we may not acquire additional loan assets without the prior written consent of the administrative agent.

On September 17, 2014, we entered into a second amendment to the Revolving Facility with Madison Capital Funding LLC to, among other things:

extend the commitment termination date from February 24, 2015 to September 17, 2017;

extend the maturity date of the Revolving Facility from February 24, 2020 to September 17, 2022 (unless terminated sooner upon certain events);

reduce the applicable margin rate on base rate borrowings from 4.50% to 3.75%, and on LIBOR borrowings from 5.50% to 4.75%; and

reduce the floor on base rate borrowings from 3.00% to 2.25%; and on LIBOR borrowings from 2.00% to 1.25%.

As of November 30, 2014, we had $4.9 million outstanding under the Credit Facility and $79.0 million SBA-guaranteed debentures outstanding (which are discussed below). As of February 28, 2014, we had no outstanding balance under the Credit Facility and $50.0 million SBA-guaranteed debentures outstanding. Our borrowing base under the Credit Facility at November 30, 2014 and February 28, 2014 was $37.1 million, and $44.6 million, respectively.

Our asset coverage ratio, as defined in the 1940 Act, was 329.9% as of November 30, 2014 and 337.9% as of February 28, 2014.

SBA-guaranteed debentures

In addition, we, through a wholly-owned subsidiary, sought and obtained a license from the SBA to operate an SBIC. In this regard, on March 28, 2012, our wholly-owned subsidiary, Saratoga Investment Corp. SBIC, LP, received a license from the SBA to operate as an SBIC under Section 301(c) of the Small Business Investment Act of 1958. SBICs are designated to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses.

The SBIC license allows our SBIC subsidiary to obtain leverage by issuing SBA-guaranteed debentures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a market-driven spread over U.S. Treasury Notes with 10-year maturities.

SBA regulations currently limit the amount that our SBIC subsidiary may borrow to a maximum of $150 million when it has at least $75 million in regulatory capital, receives a capital commitment from the SBA and has been through an examination by the SBA subsequent to licensing. As of November 30, 2014, our SBIC subsidiary had $59.3 million in regulatory capital and $79.0 million SBA-guaranteed debentures outstanding.

We received exemptive relief from the Securities and Exchange Commission to permit us to exclude the debt of our SBIC subsidiary guaranteed by the SBA from the definition of senior securities in the 200% asset coverage test under the 1940 Act. This allows us increased flexibility under the 200% asset coverage test by permitting us to borrow up to $150 million more than we would otherwise be able to absent the receipt of this exemptive relief.

Unsecured notes

In May 2013, we issued $48.3 million in aggregate principal amount of our 7.50% unsecured notes due 2020 for net proceeds of $46.1 million after deducting underwriting commissions of $1.9 million and offering costs of $0.3 million. The proceeds included the underwriters’ full exercise of their overallotment option. Interest on these notes is paid quarterly in arrears on February 15, May 15, August 15 and November 15, at a rate of 7.50% per year, beginning August 15, 2013. The notes mature on May 31, 2020 and may be redeemed in whole or in part at any time or from time to time at our option on or after May 31, 2016. In connection with the issuance of the notes, we agreed to the following covenants for the period of time during which the notes are outstanding:

we will not violate (whether or not we are subject to) Section 18(a)(1)(A) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to any exemptive relief granted to us by the SEC. Currently, these provisions generally prohibit us from making additional borrowings, including through the issuance of additional debt or the sale of additional debt securities, unless our asset coverage, as defined in the 1940 Act, equals at least 200% after such borrowings.

49


Table of Contents
we will not violate (regardless of whether we are subject to) Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act or any successor provisions, but giving effect to (i) any exemptive relief granted to us by the SEC and (ii) no-action relief granted by the SEC to another BDC (or to the Company if it determines to seek such similar no-action or other relief) permitting the BDC to declare any cash dividend or distribution notwithstanding the prohibition contained in Section 18(a)(1)(B) as modified by Section 61(a)(1) of the 1940 Act in order to maintain the BDC’s status as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986. Currently these provisions generally prohibit us from declaring any cash dividend or distribution upon any class of our capital stock, or purchasing any such capital stock if our asset coverage, as defined in the 1940 Act, is below 200% at the time of the declaration of the dividend or distribution or the purchase and after deducting the amount of such dividend, distribution or purchase.

The Notes are listed on the NYSE under the trading symbol “SAQ” with a par value of $25.00 per share.

At November 30, 2014 and February 28, 2014, the fair value of investments, cash and cash equivalents and cash and cash equivalents, securitization accounts were as follows:

At November 30,
2014
At February 28,
2014
Fair Value Percent
of
Total
Fair Value Percent
of
Total
($ in thousands)

Cash and cash equivalents

$ 809 0.3 % $ 3,294 1.6 %

Cash and cash equivalents, securitization accounts

10,738 4.2 3,293 1.6

Syndicated loans

24,523 9.7 32,390 15.2

First lien term loans

120,627 47.7 80,246 37.8

Second lien term loans

36,601 14.5 27,804 13.1

Senior secured notes

24,791 9.8 30,032 14.1

Unsecured notes

5,973 2.4 5,471 2.6

Structured finance securities

19,433 7.7 19,570 9.2

Equity Interest

9,225 3.7 10,332 4.8

Total

$ 252,720 100.0 % $ 212,432 100.0 %

On September 24, 2014, the Company declared a dividend of $0.22 per share payable on February 27, 2015. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant our DRIP.

On September 24, 2014, the Company declared a dividend of $0.18 per share payable on November 28, 2014. Shareholders had the option to receive payment of the dividend in cash, or receive shares of common stock pursuant to our DRIP. Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.

On October 30, 2013, our board of directors declared a dividend of $2.65 per share payable on December 27, 2013, to common stockholders of record on November 13, 2013. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $2.5 million or $0.53 per share. This dividend was declared in reliance on certain private letter rulings issued by the IRS concluding that a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation on the aggregate amount of cash to be distributed to all stockholders, which limitation must be at least 20.0% of the aggregate declared distribution.

Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13 and 16, 2013.

50


Table of Contents

On November 9, 2012, our board of directors declared a dividend of $4.25 per share payable on December 31, 2012, to common stockholders of record on November 20, 2012. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to approximately $3.3 million or $0.85 per share.

Based on shareholder elections, the dividend consisted of $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled the volume weighted average trading price per share of the common stock on December 14, 17 and 19, 2012.

On November 15, 2011, our board of directors declared a dividend of $3.00 per share payable on December 30, 2011, to common stockholders of record on November 25, 2011. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.0 million or $0.60 per share.

Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.

On November 12, 2010, our board of directors declared a dividend of $4.40 per share to shareholders payable in cash or shares of our common stock, in accordance with the provisions of the IRS Revenue Procedure 2010-12, which allows a publicly-traded regulated investment company to satisfy its distribution requirements with a distribution paid partly in common stock provided that at least 10.0% of the distribution is payable in cash. The dividend was paid on December 29, 2010 to common shareholders of record on November 19, 2010.

Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.

On November 13, 2009, our board of directors declared a dividend of $18.25 per share payable on December 31, 2009, to common stockholders of record on November 25, 2009. Shareholders had the option to receive payment of the dividend in cash, shares of common stock, or a combination of cash and shares of common stock, provided that the aggregate cash payable to all shareholders was limited to $2.1 million or $0.25 per share.

Based on shareholder elections, the dividend consisted of $2.1 million in cash and 8,648,725 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $1.5099 per share, which equaled the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.

We cannot provide any assurance that these measures will provide sufficient sources of liquidity to support our operations and growth.

51


Table of Contents

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at November 30, 2014:

Payment Due by Period
Total Less Than
1 Year
1 - 3
Years
3 - 5
Years
More Than
5 Years
($ in thousands)

Long-Term Debt Obligations

$ 132,200 $ $ $ $ 132,200

Off-balance sheet arrangements

The Company’s off-balance sheet arrangements consisted of $12.8 million and $12.2 million of unfunded commitments to provide debt financing to its portfolio companies or to fund limited partnership interests as of November 30, 2014 and February 28, 2014, respectively. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s Consolidated Statement of Assets and Liabilities and are not reflected in the Company’s Consolidated Statements of Assets and Liabilities.

On July 10, 2014, our board of directors appointed Henri J. Steenkamp to serve as our Chief Financial Officer and Chief Compliance Officer. As previously disclosed, Mr. Steenkamp was previously appointed to serve as our Interim Chief Financial Officer and Interim Chief Compliance Officer on March 4, 2014.

On July 10, 2014, our board of directors, including a majority of the independent directors, approved the annual continuation of our investment advisory and management agreement with Saratoga Investment Advisors, LLC. Our board of directors also approved the renewal of the administration agreement with Saratoga Investment Advisors, LLC for an additional one-year term and determined to maintain the cap on the payment or reimbursement of expenses by us thereunder to $1.0 million for the additional one-year term.

Recent Developments

None.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Our market risks have not changed materially from the risks reported in our Form 10-K for the year ended February 28, 2014.

Item 4. Controls and Procedures

(a) As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). Based on that evaluation, our chief executive officer and our chief financial officer have concluded that our current disclosure controls and procedures are effective in facilitating timely decisions regarding required disclosure of any material information relating to us that is required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934.

(b) There have been no changes in our internal control over financial reporting that occurred during the quarter ended November 30, 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

On August 31, 2012, a complaint was filed in the United States Bankruptcy Court for the Southern District of New York by GSC Acquisition Holdings, LLC against us to recover, among other things, approximately $2.6 million for the benefit of the estates and the general unsecured creditors of GSC Group, Inc. and its affiliates, including the Company’s former investment adviser, GSCP

52


Table of Contents

(NJ), L.P. The complaint alleges that the former investment adviser made a constructively fraudulent transfer of $2.6 million in deferred incentive fees by waiving them in connection with the termination of the Management Agreement with us, and that the termination of the Management Agreement was itself a fraudulent transfer. These transfers, the complaint alleges, were made without receipt of reasonably equivalent value and while the former investment adviser was insolvent. The complaint has not yet been served, and the plaintiff’s motion for authority to prosecute the case on behalf of the estates was taken under advisement by the court on October 1, 2012. We opposed that motion. We believe that the claims in this lawsuit are without merit and, if the plaintiff is authorized to proceed, intend to vigorously defend against this action.

Except as discussed above, neither we nor our wholly-owned subsidiaries, Saratoga Investment Funding LLC and Saratoga Investment Corp. SBIC LP, are currently subject to any material legal proceedings.

Item 1A. Risk Factors

Other than as set forth below, there have been no material changes from the risk factors set forth in our annual report on Form 10-K for the year ended February 28, 2014.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Not applicable.

Item 3. Defaults upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

Not applicable.

Item 6. Exhibits

Listed below are the exhibits which are filed as part of this report (according to the number assigned to them in Item 601 of Regulation S-K):

Exhibit

Number

Description of Document

31.1* Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
31.2* Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
32.1* Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)
32.2* Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)

* Submitted herewith.

53


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SARATOGA INVESTMENT CORP.
Date: January 14, 2015 By

/s/ CHRISTIAN L. OBERBECK

Christian L. Oberbeck
Chief Executive Officer
By

/s/ HENRI J. STEENKAMP

Henri J. Steenkamp
Chief Financial Officer and Chief Compliance Officer

54

TABLE OF CONTENTS